Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"MS evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific NX"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific NX"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific NX"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific NX"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific NX"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific pTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific pTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [NX]"	"Tissue RNA - adrenal gland [NX]"	"Tissue RNA - amygdala [NX]"	"Tissue RNA - appendix [NX]"	"Tissue RNA - basal ganglia [NX]"	"Tissue RNA - bone marrow [NX]"	"Tissue RNA - breast [NX]"	"Tissue RNA - cerebellum [NX]"	"Tissue RNA - cerebral cortex [NX]"	"Tissue RNA - cervix, uterine [NX]"	"Tissue RNA - colon [NX]"	"Tissue RNA - corpus callosum [NX]"	"Tissue RNA - ductus deferens [NX]"	"Tissue RNA - duodenum [NX]"	"Tissue RNA - endometrium 1 [NX]"	"Tissue RNA - epididymis [NX]"	"Tissue RNA - esophagus [NX]"	"Tissue RNA - fallopian tube [NX]"	"Tissue RNA - gallbladder [NX]"	"Tissue RNA - heart muscle [NX]"	"Tissue RNA - hippocampal formation [NX]"	"Tissue RNA - hypothalamus [NX]"	"Tissue RNA - kidney [NX]"	"Tissue RNA - liver [NX]"	"Tissue RNA - lung [NX]"	"Tissue RNA - lymph node [NX]"	"Tissue RNA - midbrain [NX]"	"Tissue RNA - olfactory region [NX]"	"Tissue RNA - ovary [NX]"	"Tissue RNA - pancreas [NX]"	"Tissue RNA - parathyroid gland [NX]"	"Tissue RNA - pituitary gland [NX]"	"Tissue RNA - placenta [NX]"	"Tissue RNA - pons and medulla [NX]"	"Tissue RNA - prostate [NX]"	"Tissue RNA - rectum [NX]"	"Tissue RNA - retina [NX]"	"Tissue RNA - salivary gland [NX]"	"Tissue RNA - seminal vesicle [NX]"	"Tissue RNA - skeletal muscle [NX]"	"Tissue RNA - skin 1 [NX]"	"Tissue RNA - small intestine [NX]"	"Tissue RNA - smooth muscle [NX]"	"Tissue RNA - spinal cord [NX]"	"Tissue RNA - spleen [NX]"	"Tissue RNA - stomach 1 [NX]"	"Tissue RNA - testis [NX]"	"Tissue RNA - thalamus [NX]"	"Tissue RNA - thymus [NX]"	"Tissue RNA - thyroid gland [NX]"	"Tissue RNA - tongue [NX]"	"Tissue RNA - tonsil [NX]"	"Tissue RNA - urinary bladder [NX]"	"Tissue RNA - vagina [NX]"	"Tissue RNA - B-cells [NX]"	"Tissue RNA - dendritic cells [NX]"	"Tissue RNA - granulocytes [NX]"	"Tissue RNA - monocytes [NX]"	"Tissue RNA - NK-cells [NX]"	"Tissue RNA - T-cells [NX]"	"Tissue RNA - total PBMC [NX]"	"Cell RNA - A-431 [NX]"	"Cell RNA - A549 [NX]"	"Cell RNA - AF22 [NX]"	"Cell RNA - AN3-CA [NX]"	"Cell RNA - ASC diff [NX]"	"Cell RNA - ASC TERT1 [NX]"	"Cell RNA - BEWO [NX]"	"Cell RNA - BJ [NX]"	"Cell RNA - BJ hTERT+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]"	"Cell RNA - CACO-2 [NX]"	"Cell RNA - CAPAN-2 [NX]"	"Cell RNA - Daudi [NX]"	"Cell RNA - EFO-21 [NX]"	"Cell RNA - fHDF/TERT166 [NX]"	"Cell RNA - HaCaT [NX]"	"Cell RNA - HAP1 [NX]"	"Cell RNA - HBEC3-KT [NX]"	"Cell RNA - HBF TERT88 [NX]"	"Cell RNA - HDLM-2 [NX]"	"Cell RNA - HEK 293 [NX]"	"Cell RNA - HEL [NX]"	"Cell RNA - HeLa [NX]"	"Cell RNA - Hep G2 [NX]"	"Cell RNA - HHSteC [NX]"	"Cell RNA - HL-60 [NX]"	"Cell RNA - HMC-1 [NX]"	"Cell RNA - HSkMC [NX]"	"Cell RNA - hTCEpi [NX]"	"Cell RNA - hTEC/SVTERT24-B [NX]"	"Cell RNA - hTERT-HME1 [NX]"	"Cell RNA - HUVEC TERT2 [NX]"	"Cell RNA - K-562 [NX]"	"Cell RNA - Karpas-707 [NX]"	"Cell RNA - LHCN-M2 [NX]"	"Cell RNA - MCF7 [NX]"	"Cell RNA - MOLT-4 [NX]"	"Cell RNA - NB-4 [NX]"	"Cell RNA - NTERA-2 [NX]"	"Cell RNA - PC-3 [NX]"	"Cell RNA - REH [NX]"	"Cell RNA - RH-30 [NX]"	"Cell RNA - RPMI-8226 [NX]"	"Cell RNA - RPTEC TERT1 [NX]"	"Cell RNA - RT4 [NX]"	"Cell RNA - SCLC-21H [NX]"	"Cell RNA - SH-SY5Y [NX]"	"Cell RNA - SiHa [NX]"	"Cell RNA - SK-BR-3 [NX]"	"Cell RNA - SK-MEL-30 [NX]"	"Cell RNA - T-47d [NX]"	"Cell RNA - THP-1 [NX]"	"Cell RNA - TIME [NX]"	"Cell RNA - U-138 MG [NX]"	"Cell RNA - U-2 OS [NX]"	"Cell RNA - U-2197 [NX]"	"Cell RNA - U-251 MG [NX]"	"Cell RNA - U-266/70 [NX]"	"Cell RNA - U-266/84 [NX]"	"Cell RNA - U-698 [NX]"	"Cell RNA - U-87 MG [NX]"	"Cell RNA - U-937 [NX]"	"Cell RNA - WM-115 [NX]"	"Blood RNA - basophil [NX]"	"Blood RNA - classical monocyte [NX]"	"Blood RNA - eosinophil [NX]"	"Blood RNA - gdTCR [NX]"	"Blood RNA - intermediate monocyte [NX]"	"Blood RNA - MAIT T-cell [NX]"	"Blood RNA - memory B-cell [NX]"	"Blood RNA - memory CD4 T-cell [NX]"	"Blood RNA - memory CD8 T-cell [NX]"	"Blood RNA - myeloid DC [NX]"	"Blood RNA - naive B-cell [NX]"	"Blood RNA - naive CD4 T-cell [NX]"	"Blood RNA - naive CD8 T-cell [NX]"	"Blood RNA - neutrophil [NX]"	"Blood RNA - NK-cell [NX]"	"Blood RNA - non-classical monocyte [NX]"	"Blood RNA - plasmacytoid DC [NX]"	"Blood RNA - T-reg [NX]"	"Blood RNA - total PBMC [NX]"	"Brain RNA - amygdala [NX]"	"Brain RNA - basal ganglia [NX]"	"Brain RNA - cerebellum [NX]"	"Brain RNA - cerebral cortex [NX]"	"Brain RNA - hippocampal formation [NX]"	"Brain RNA - hypothalamus [NX]"	"Brain RNA - midbrain [NX]"	"Brain RNA - olfactory region [NX]"	"Brain RNA - pons and medulla [NX]"	"Brain RNA - thalamus [NX]"
AC233724.16		ENSG00000283776			5	17632088-17632684	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enriched"	"Detected in single"	12	"urinary bladder: 1.4"	"Cell line enriched"	"Detected in single"	26	"U-2 OS: 3.3"									"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.1			0.0		0.0	1.4		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
CCR8	"CDw198, CKR-L1, CMKBR8, CMKBRL2, CY6, GPR-CY6, TER1"	ENSG00000179934	"C-C motif chemokine receptor 8"	P51685	3	39329706-39333511	"CD markers, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	7	"blood: 19.8;lymphoid tissue: 19.3;urinary bladder: 5.3"	"Cell line enriched"	"Detected in some"	22	"HDLM-2: 48.9"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	5	"T-reg: 19.8"	"Lineage enriched"	"Detected in single"	30	"T-cells: 19.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA042383	Enhanced									"HPA042383: AB_2732497"	"unprognostic (2.16e-1)"	"unprognostic (2.12e-2)"	"unprognostic (2.91e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.38e-2)"	"unprognostic (7.63e-4)"	"unprognostic (3.31e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.30e-3)"	"unprognostic (3.37e-2)"	"unprognostic (7.40e-2)"	"unprognostic (2.99e-1)"	"unprognostic (4.65e-8)"	"unprognostic (7.96e-2)"	"unprognostic (2.24e-2)"	"unprognostic (2.56e-1)"	"unprognostic (4.14e-1)"	0.3	0.2	0.2	3.1	0.2	0.0	0.3	0.2	0.2	0.3	0.5	0.1	0.1	0.0	0.3	0.1	0.8	0.1	2.1	0.2	0.2	0.2	0.5	0.3	1.4	2.8	0.1	0.1	0.2	0.3	0.0	0.2	0.1	0.1	0.4	1.3	0.1	0.5	0.1	0.2	1.0	1.2	0.1	0.4	1.7	0.8	0.3	0.1	19.3	0.4	1.2	3.5	5.3	0.3	0.0	0.0	0.0	0.0	0.6	19.8	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	48.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.2	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	1.8	0.0	0.0	0.2	0.0	0.0	0.6	0.0	0.0	19.8	0.6	0.2	0.2	0.2	0.2	0.2	0.2	0.1	0.1	0.1	0.1
CYP1A1	"CP11, CYP1, P1-450, P450-C, P450DX"	ENSG00000140465	"Cytochrome P450 family 1 subfamily A member 1"	P04798	15	74719542-74725610	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"liver: 38.3;lung: 144.1;urinary bladder: 40.0"	"Cell line enhanced"	"Detected in some"		"CACO-2: 24.0;hTCEpi: 13.1;HUVEC TERT2: 12.6;SK-BR-3: 9.8"	"Group enriched"	"Detected in some"	24	"liver cancer: 18.6;urothelial cancer: 54.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			CAB018654	Uncertain									"CAB018654: AB_2088699"	"unprognostic (1.71e-2)"	"unprognostic (7.86e-2)"	"unprognostic (2.57e-2)"	"unprognostic (2.89e-1)"	"unprognostic (5.45e-3)"	"unprognostic (6.34e-2)"	"unprognostic (3.08e-1)"	"unprognostic (6.24e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.03e-1)"	"unprognostic (4.21e-2)"	"unprognostic (6.70e-2)"	"unprognostic (2.20e-1)"	"unprognostic (4.77e-1)"	"unprognostic (1.28e-1)"	9.3	0.4	0.1	0.4	0.2	0.2	7.7	0.2	0.5	2.3	0.7	0.4	3.9	0.5	3.8	4.4	1.2	0.2	11.3	3.0	0.1	0.0	0.7	38.3	144.1	0.2	0.1	0.1	0.5	0.5	0.2	0.1	3.5	0.3	0.2	0.2	0.8	2.1	0.5	1.5	8.1	10.7	5.9	0.2	0.2	0.4	0.3	0.1	0.1	0.8	0.8	8.0	40.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	1.4	0.1	0.0	0.3	0.0	7.8	0.0	0.1	0.4	0.2	24.0	1.0	0.2	6.5	0.0	7.5	0.5	4.8	0.2	0.0	0.7	0.3	1.7	3.5	0.1	0.2	7.7	0.0	13.1	0.2	1.0	12.6	1.4	0.2	0.0	0.5	0.0	0.2	0.1	1.9	0.7	0.0	0.3	0.0	1.6	0.4	0.2	1.1	9.8	2.5	0.3	0.1	0.6	1.1	0.3	3.5	0.0	0.5	0.1	0.3	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.2	0.2	0.3	0.1	0.0	0.1	0.1	0.3	0.1
IL17A	"CTLA8, IL-17, IL-17A, IL17"	ENSG00000112115	"Interleukin 17A"	Q16552	6	52186387-52190638	"Cancer-related genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"lymphoid tissue: 7.6;tongue: 12.2;urinary bladder: 4.4"	"Group enriched"	"Detected in some"	37	"Karpas-707: 7.2;U-266/84: 4.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA052258	Uncertain				"Secreted to blood"					"HPA052258: "		"unprognostic (5.55e-1)"	"unprognostic (2.18e-4)"			"unprognostic (3.05e-4)"		"unprognostic (1.41e-2)"						"unprognostic (2.22e-2)"				0.2	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.4	0.0	0.0	1.3	0.5	0.6	0.0	0.1	0.0	0.1	0.1	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.1	0.0	0.1	0.1	1.0	0.1	0.0	0.1	0.3	0.1	0.0	0.0	0.0	12.2	7.6	4.4	0.5	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0
IL17F	"IL-17F, ML-1, ML1"	ENSG00000112116	"Interleukin 17F"	Q96PD4	6	52236681-52244537	"Disease related genes, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	6	"esophagus: 2.2;lymphoid tissue: 6.4;urinary bladder: 2.4"	"Cell line enhanced"	"Detected in single"		"Karpas-707: 2.7"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"								"Secreted to blood"							"unprognostic (1.40e-1)"	"unprognostic (1.20e-1)"											"unprognostic (3.02e-1)"	"unprognostic (2.52e-1)"			0.0	0.0	0.1	1.7	0.3	0.0	0.0	0.6	0.2	0.1	0.0			0.0	0.0	0.1	2.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.3	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.1		0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.2			0.0		6.4	2.4	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3										
TBC1D3H		ENSG00000274226	"TBC1 domain family member 3H"	P0C7X1	17	36377531-36388423	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	6	"cervix, uterine: 1.6;testis: 5.0;urinary bladder: 3.3"	"Cell line enriched"	"Detected in some"	10	"CAPAN-2: 11.2"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA046969, HPA047745, HPA052553"	Approved		Approved	Vesicles				Vesicles	Vesicles	"HPA046969: , HPA047745: AB_2680144, HPA052553: "																		0.0	0.0		0.0		0.2	0.0		0.0	1.6	0.0			0.0	0.2	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.5	0.0	0.0	0.0	0.0	0.0		0.0	0.0	5.0			0.0		0.0	3.3		0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.2	0.0	0.0	0.0	1.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1										
UPK2	"MGC138598, UP2, UPII"	ENSG00000110375	"Uroplakin 2"	O00526	11	118925164-118958559	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"prostate: 39.0;urinary bladder: 52.4;vagina: 25.9"	"Group enriched"	"Detected in some"	6	"MCF7: 45.9;RT4: 51.8"	"Cancer enriched"	"Detected in many"	72	"urothelial cancer: 339.4"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"NK-cell: 2.0;T-reg: 1.9"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA043312, HPA061106"	Enhanced									"HPA043312: AB_2678420, HPA061106: AB_2684429"	"unprognostic (6.04e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.97e-2)"	"unprognostic (1.21e-1)"	"unprognostic (4.12e-4)"	"unprognostic (1.65e-1)"	"prognostic unfavourable (9.57e-4)"	"unprognostic (3.13e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.05e-3)"	"unprognostic (6.35e-3)"	"prognostic unfavourable (7.30e-7)"	"unprognostic (6.69e-2)"	"unprognostic (7.45e-2)"	"unprognostic (2.98e-1)"	"unprognostic (1.00e-1)"	1.0	0.0	0.2	0.0	0.3	0.0	0.1	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.5	1.0	0.1	0.0	0.0	0.2	0.2	0.8	0.0	0.1	0.0	0.1	0.0	0.0	0.4	0.0	0.0	3.8	0.0	39.0	0.0	0.0	0.2	0.1	0.1	0.1	0.0	6.8	0.1	0.1	0.1	0.2	0.0	0.2	0.0	0.2	1.3	52.4	25.9	0.7	0.6	0.0	0.1	2.0	1.9	0.2	1.2	0.1	0.0	0.1	0.0	0.0	8.6	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.1	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	45.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	51.8	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.1	0.0	0.7	0.2	0.0	0.0	0.0	0.0	0.4	0.0	2.0	0.0	0.6	1.9	0.2	0.2	0.3	0.1	0.1	0.2	0.2	0.1	0.0	0.0	0.0
IFNA1	"IFL, IFN, IFN-ALPHA, IFN-alphaD, IFNA@, IFNA13"	ENSG00000197919	"Interferon alpha 1"	P01562	9	21440454-21441316	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 2.3;urinary bladder: 2.1"	"Cell line enhanced"	"Detected in some"		"A549: 1.7;BJ: 1.0;HeLa: 6.6;NB-4: 1.5"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	13	"cerebellum: 2.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA047557	Uncertain				"Secreted to blood"					"HPA047557: AB_2680087"		"unprognostic (3.14e-1)"				"unprognostic (1.55e-1)"							"unprognostic (9.75e-2)"			"unprognostic (5.88e-2)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.1	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0
TBX4		ENSG00000121075	"T-box 4"	P57082	17	61452404-61485110	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	5	"lung: 31.1;placenta: 17.0;prostate: 15.0;smooth muscle: 26.0;urinary bladder: 18.6"	"Cell line enhanced"	"Detected in some"		"BJ: 5.3;Hep G2: 2.1;THP-1: 10.5"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Region enhanced"	"Detected in some"		"basal ganglia: 1.6"	"CAB032413, HPA044457"	Uncertain		Approved	Vesicles				Vesicles	Vesicles	"CAB032413: AB_2200705, HPA044457: AB_2678948"	"unprognostic (1.03e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.63e-3)"	"unprognostic (6.07e-2)"	"unprognostic (3.80e-2)"	"unprognostic (1.25e-2)"	"unprognostic (4.14e-2)"	"unprognostic (7.77e-3)"	"unprognostic (7.41e-2)"	"unprognostic (6.83e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.46e-8)"	"unprognostic (1.92e-1)"	"unprognostic (4.41e-2)"	"unprognostic (6.15e-2)"	"unprognostic (5.39e-2)"	0.5	0.1	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.3	0.1	0.0	0.0	0.0	0.0	31.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	17.0	0.6	15.0	0.0	0.0	0.1	0.0	0.1	0.3	0.1	26.0	0.0	0.0	0.1	0.9	0.0	0.0	0.1	0.0	0.0	18.6	4.2	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.9	0.1	0.0	0.0	5.3	0.5	0.4	0.4	1.9	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.3	0.0	0.8	0.0	0.0	2.1	0.5	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.1	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.3	1.1	0.0	0.0	0.5	0.0	10.5	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0
UGT1A6	"GNT1, HLUGP, UGT1F"	ENSG00000167165	"UDP glucuronosyltransferase family 1 member A6"	P19224	2	233691607-233773300	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"kidney: 111.7;liver: 50.1;urinary bladder: 32.7"	"Cell line enhanced"	"Detected in some"		"CACO-2: 13.4;EFO-21: 20.8;HaCaT: 74.4;RT4: 37.6"	"Cancer enhanced"	"Detected in many"		"renal cancer: 7.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"CAB009819, HPA054065"	Enhanced									"CAB009819: AB_2241481, HPA054065: AB_2682367"		"unprognostic (9.09e-2)"	"unprognostic (6.07e-2)"	"unprognostic (5.43e-2)"		"unprognostic (6.03e-2)"	"prognostic unfavourable (2.89e-6)"	"unprognostic (2.79e-1)"	"unprognostic (6.18e-2)"		"unprognostic (2.09e-3)"	"unprognostic (9.97e-2)"	"unprognostic (2.16e-2)"	"unprognostic (3.52e-1)"	"unprognostic (7.50e-2)"		"unprognostic (2.01e-2)"	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.8	0.5	0.2	0.5	2.0	0.3	0.9	13.0	0.0	1.1	0.1	0.1	0.0	111.7	50.1	1.9	0.1	0.1	0.1	0.1	0.1	0.0	0.5	0.3	0.1	3.3	0.4	0.1	1.3	1.2	0.1	3.8	1.2	2.3	0.1	0.1	8.1	0.2	0.1	0.5	0.2	5.6	8.7	32.7	2.9	0.0	0.0	0.0	0.0	0.8	0.0	0.0	1.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.4	0.4	0.0	20.8	0.0	74.4	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	8.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	37.6	0.0	0.0	1.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
AC233755.1		ENSG00000275063	"Immunoglobulin heavy variable 4-38-2 "	P0DP08	Unmapped	41444-41876	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"		"Group enriched"	"Detected in many"	4	"blood: 75.1;intestine: 32.1;lymphoid tissue: 37.1;urinary bladder: 45.9"	"Cell line enriched"	"Detected in some"	8	"REH: 54.7"									"Group enriched"	"Detected in some"	363	"memory B-cell: 75.1;naive B-cell: 42.7"	"Lineage enriched"	"Detected in single"	463	"B-cells: 75.1"														"Secreted to blood"																							0.8	0.0		14.4		2.6	2.8		0.0	10.9	32.1			24.1	0.0	0.0	4.3	0.0	1.0	0.0			0.0	0.0	0.7	5.5			0.0	0.0	0.0		0.0		0.0	11.1		11.1	0.0	0.0	0.0	6.4	0.6		9.4	11.7	0.0			0.0		37.1	45.9		75.1	0.1	0.1	0.0	0.0	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	7.2	0.1	0.1	0.0	54.7	0.6	1.2	0.0	0.0	0.0	3.6	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	1.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	75.1	0.0	0.0	0.0	42.7	0.0	0.0	0.1	0.0	0.0	0.1	0.0	6.0										
BTBD16	"C10orf87, Em:AC061711.1, FLJ25359"	ENSG00000138152	"BTB domain containing 16"	Q32M84	10	122271306-122338162	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"skin 1: 9.1;testis: 27.6;urinary bladder: 17.9"	"Cell line enriched"	"Detected in some"	8	"RT4: 26.9"	"Cancer enriched"	"Detected in many"	14	"urothelial cancer: 18.4"	"Low region specificity"	"Detected in single"			"Cell type enriched"	"Detected in single"	29	"T-reg: 2.8"	"Lineage enriched"	"Detected in single"	29	"T-cells: 2.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"HPA040529, HPA057638"	Uncertain		Uncertain	Nucleoli,Cytosol				Nucleoli	Nucleoli	"HPA040529: AB_2677022, HPA057638: "	"unprognostic (1.41e-4)"	"unprognostic (1.33e-1)"	"unprognostic (5.97e-2)"	"unprognostic (5.98e-3)"	"unprognostic (2.08e-1)"	"unprognostic (2.09e-3)"	"unprognostic (2.88e-1)"	"unprognostic (4.54e-2)"	"unprognostic (1.76e-1)"	"unprognostic (6.85e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.77e-1)"	"prognostic unfavourable (1.50e-4)"	"unprognostic (1.08e-1)"	"unprognostic (1.60e-1)"	"unprognostic (9.12e-2)"	"unprognostic (9.44e-3)"	0.3	0.0	0.6	0.3	0.5	0.0	0.5	0.3	0.3	0.3	0.3	0.3	0.3	0.0	0.6	0.3	0.3	0.2	0.3	0.3	0.9	0.4	0.3	4.4	0.3	0.3	1.2	0.3	0.3	0.3	0.0	0.3	0.3	0.3	0.3	0.0	0.3	0.4	0.3	0.3	9.1	0.3	0.3	2.3	0.3	0.0	27.6	0.3	0.3	0.3	0.3	0.3	17.9	0.3	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.1	3.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.2	26.9	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.6	0.5	0.3	0.3	0.9	0.4	1.2	0.3	0.3	0.3
COL19A1		ENSG00000082293	"Collagen type XIX alpha 1 chain"	Q14993	6	69866571-70209976	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 23.1;brain: 14.4;lymphoid tissue: 18.8;smooth muscle: 37.8;urinary bladder: 12.4"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 5.5;RH-30: 14.2;SCLC-21H: 4.0;SK-MEL-30: 11.9;WM-115: 10.0"	"Cancer enhanced"	"Detected in single"		"melanoma: 0.7"	"Region enhanced"	"Detected in many"		"cerebellum: 14.4"	"Group enriched"	"Detected in some"	156	"memory B-cell: 7.9;naive B-cell: 23.1"	"Lineage enriched"	"Detected in single"	232	"B-cells: 23.1"	"Low region specificity"	"Detected in many"							HPA042422	Uncertain				"Secreted to extracellular matrix"					"HPA042422: AB_10794798"	"unprognostic (2.65e-2)"	"unprognostic (2.55e-1)"	"unprognostic (2.71e-1)"	"unprognostic (9.24e-2)"	"unprognostic (2.26e-2)"	"unprognostic (6.20e-2)"	"unprognostic (3.17e-1)"	"unprognostic (1.10e-3)"	"unprognostic (3.41e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.62e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.20e-1)"	"unprognostic (3.35e-1)"	"unprognostic (8.91e-2)"	4.2	0.7	1.1	18.8	2.7	1.1	0.5	14.4	4.1	0.5	1.6	0.0	0.0	0.8	0.5	0.2	0.6	0.7	0.6	2.6	6.0	1.0	4.5	0.6	0.6	7.3	0.7	1.1	0.5	0.9	0.2	4.2	0.4	0.7	5.2	2.2	0.0	0.8	0.4	3.7	0.5	2.3	37.8	0.6	4.2	4.4	1.5	0.0	1.3	0.6	0.0	8.8	12.4	2.3	23.1	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	5.5	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.6	0.1	0.0	0.0	0.0	0.2	0.0	0.0	14.2	0.0	0.0	0.0	4.0	2.9	0.0	0.0	11.9	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	10.0	0.0	0.0	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.0	23.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.1	2.7	14.4	4.1	6.0	1.0	0.7	1.1	0.7	0.0
GPR15		ENSG00000154165	"G protein-coupled receptor 15"	P49685	3	98531899-98533150	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 12.9;intestine: 27.1;lymphoid tissue: 26.3;urinary bladder: 9.4"	"Group enriched"	"Detected in some"	22	"HDLM-2: 10.9;U-266/70: 4.8"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"memory B-cell: 4.4;memory CD4 T-cell: 12.9;memory CD8 T-cell: 6.1;T-reg: 12.9"	"Group enriched"	"Detected in many"	30	"B-cells: 4.4;T-cells: 12.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA013775	Approved									"HPA013775: AB_1849264"	"unprognostic (8.03e-2)"	"unprognostic (1.04e-2)"	"unprognostic (3.72e-3)"	"unprognostic (5.66e-2)"	"unprognostic (9.48e-3)"	"unprognostic (5.60e-5)"	"unprognostic (5.17e-1)"	"unprognostic (6.77e-3)"	"unprognostic (3.96e-1)"	"unprognostic (3.03e-2)"	"unprognostic (2.82e-1)"	"unprognostic (2.83e-1)"	"unprognostic (4.04e-3)"	"unprognostic (4.23e-3)"	"unprognostic (1.89e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.54e-1)"	0.9	0.1	0.1	13.4	0.1	0.0	2.5	0.1	0.2	1.1	15.3	0.1	0.1	1.8	0.1	0.1	2.6	0.2	2.1	0.2	0.1	0.1	0.3	0.4	1.9	24.9	0.1	0.4	0.4	0.1	0.0	0.2	0.1	0.3	1.4	27.1	0.3	4.6	0.7	0.1	0.4	11.8	1.5	0.2	4.3	1.1	0.2	0.1	3.6	0.7	2.0	26.3	9.4	2.4	4.4	0.2	0.2	0.0	0.0	12.9	2.8	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.9	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	4.8	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	1.7	0.0	0.4	4.4	12.9	6.1	0.0	0.7	0.6	1.0	0.2	0.0	0.0	0.2	12.9	2.8	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.4	0.3	0.1
LY9	"CD229, hly9, mLY9, SLAMF3"	ENSG00000122224	"Lymphocyte antigen 9"	Q9HBG7	1	160796074-160828261	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 30.8;intestine: 11.3;lymphoid tissue: 43.7;urinary bladder: 28.6"	"Cell line enhanced"	"Detected in some"		"Daudi: 7.2;Karpas-707: 14.6;U-266/70: 37.2;U-266/84: 14.3"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"gdTCR: 30.6;MAIT T-cell: 30.7;memory B-cell: 15.2;memory CD4 T-cell: 26.8;memory CD8 T-cell: 29.6;naive B-cell: 13.9;naive CD4 T-cell: 30.5;naive CD8 T-cell: 30.8;plasmacytoid DC: 18.6;T-reg: 19.7"	"Group enriched"	"Detected in many"	4	"B-cells: 15.2;dendritic cells: 18.6;T-cells: 30.8"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA050917	Approved					23000	23000			"HPA050917: AB_2681272"	"unprognostic (8.04e-4)"	"unprognostic (2.31e-5)"	"unprognostic (8.08e-3)"	"unprognostic (1.20e-3)"	"unprognostic (9.83e-3)"	"unprognostic (1.87e-5)"	"unprognostic (1.16e-2)"	"unprognostic (3.84e-3)"	"unprognostic (1.23e-2)"	"unprognostic (2.89e-3)"	"unprognostic (1.64e-1)"	"unprognostic (2.30e-1)"	"unprognostic (2.70e-3)"	"unprognostic (8.69e-2)"	"unprognostic (9.47e-2)"	"unprognostic (3.49e-2)"	"unprognostic (6.88e-2)"	2.8	0.5	0.4	20.9	0.4	6.9	2.7	0.4	0.4	1.4	3.7	0.2	0.4	2.4	0.9	0.8	3.5	1.0	2.0	0.9	0.4	0.4	1.7	1.3	6.1	35.3	0.4	0.0	1.1	0.5	0.0	0.5	0.2	0.1	1.0	2.3	1.0	6.5	0.4	0.4	0.8	11.3	0.1	0.7	25.3	3.4	1.1	0.0	35.7	1.6	1.8	43.7	28.6	1.2	15.2	18.6	0.6	0.2	5.2	30.8	12.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	14.6	0.0	0.0	1.1	0.2	0.0	0.0	0.8	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	37.2	14.3	0.1	0.0	2.0	0.0	0.2	0.2	0.1	30.6	0.2	30.7	15.2	26.8	29.6	1.3	13.9	30.5	30.8	0.6	5.2	0.2	18.6	19.7	12.9	0.4	0.4	0.4	0.4	0.4	0.4	0.4	0.0	0.1	0.0
OR1Q1	"HSTPCR106, OR1Q2, OR1Q3, OR9-A, OST226, OST226OR9-A, TPCR106"	ENSG00000165202	"Olfactory receptor family 1 subfamily Q member 1"	Q15612	9	122614738-122615682	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	4	"epididymis: 4.4;urinary bladder: 1.6"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 3.2;CAPAN-2: 1.4;fHDF/TERT166: 2.3;HSkMC: 1.4;Karpas-707: 1.6"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA044828	Uncertain									"HPA044828: AB_10960565"										"unprognostic (5.41e-2)"				"unprognostic (2.00e-1)"			"unprognostic (1.98e-1)"	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.4	0.1	0.2			0.0	0.7	4.4	0.2	0.5	0.7	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0		0.0	0.0	0.0	0.4	0.2		0.2	0.2		0.3	0.1	0.0	0.4	0.3	0.0	0.0	0.1	0.4	0.3			0.0		0.1	1.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.1	0.0	1.2	0.2	1.0	3.2	0.0	0.0	0.0	1.4	0.0	0.2	2.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.4	0.3	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.9	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.4	0.0	0.0	1.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
OR5P2	JCG3	ENSG00000183303	"Olfactory receptor family 5 subfamily P member 2"	Q8WZ92	11	7795905-7796973	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	4	"skin 1: 1.7;urinary bladder: 1.3"	"Cell line enhanced"	"Detected in single"		"RT4: 1.0"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.3	0.0		0.3	0.1	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0			0.0		0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
PRAC2	"C17orf93, HOXB-AS5, HOXB13-AS1, NCRNA00253"	ENSG00000229637	"Prostate cancer susceptibility candidate 2"	D3DTV9	17	48723168-48724758	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Group enriched"	"Detected in some"	4	"intestine: 11.2;prostate: 12.8;urinary bladder: 3.4"	"Group enriched"	"Detected in some"	5	"PC-3: 31.3;REH: 12.2"	"Cancer enriched"	"Detected in many"	8	"prostate cancer: 26.6"					"Not detected"	"Not detected"			"Not detected"	"Not detected"																"Intracellular and membrane"						"unprognostic (1.22e-2)"	"unprognostic (1.45e-1)"	"unprognostic (4.26e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.63e-2)"			"unprognostic (9.98e-2)"	"unprognostic (3.27e-2)"		"unprognostic (9.77e-2)"	"unprognostic (8.97e-2)"		"unprognostic (1.01e-1)"	"unprognostic (1.82e-1)"		"unprognostic (1.82e-1)"	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	5.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	12.8	11.2	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	4.3	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	31.3	12.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
SLC14A1	"HsT1341, JK, RACH1, RACH2"	ENSG00000141469	"Solute carrier family 14 member 1 (Kidd blood group)"	Q13336	18	45687025-45752520	"Blood group antigen proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 44.5;prostate: 64.7;urinary bladder: 29.6"	"Cell line enriched"	"Detected in some"	14	"RT4: 49.9"	"Group enriched"	"Detected in many"	5	"glioma: 5.3;prostate cancer: 8.6;urothelial cancer: 16.1"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"eosinophil: 2.4;gdTCR: 2.0;memory CD4 T-cell: 2.0;memory CD8 T-cell: 2.4;naive CD8 T-cell: 3.4;NK-cell: 1.8;T-reg: 7.2"	"Group enriched"	"Detected in many"	5	"granulocytes: 2.4;NK-cells: 1.8;T-cells: 7.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059570, HPA077233"	Supported		Supported	"Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"HPA059570: AB_2684066, HPA077233: "	"unprognostic (2.04e-1)"	"unprognostic (2.56e-3)"	"unprognostic (5.20e-2)"	"unprognostic (1.27e-1)"	"unprognostic (6.86e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.70e-2)"	"unprognostic (7.97e-2)"	"unprognostic (8.17e-2)"	"unprognostic (9.99e-2)"	"unprognostic (2.69e-1)"	"unprognostic (1.42e-1)"	"unprognostic (3.02e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.52e-1)"	"unprognostic (9.09e-2)"	"unprognostic (6.93e-2)"	2.2	2.1	15.6	1.5	21.5	10.3	2.4	4.6	24.2	2.9	1.6	33.7	0.0	1.9	1.1	1.4	1.1	1.0	8.7	8.2	33.7	11.7	10.1	1.5	4.1	2.4	28.0	23.4	1.0	1.5	1.2	0.4	2.0	44.5	64.7	1.8	0.0	2.6	3.2	3.4	1.7	2.1	3.9	34.9	2.6	2.0	1.0	44.0	0.0	3.6	0.0	2.6	29.6	3.0	0.7	0.3	2.4	0.1	1.8	7.2	1.1	0.0	0.1	0.0	0.0	0.0	0.1	0.3	0.1	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.3	0.1	0.0	0.1	0.0	0.0	0.0	1.3	49.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.2	0.4	0.0	1.9	0.0	0.0	1.1	0.5	0.5	0.1	0.1	2.4	2.0	0.0	0.1	0.6	2.0	2.4	0.0	0.7	0.5	3.4	0.4	1.8	0.0	0.3	7.2	1.1	15.6	21.5	4.6	24.2	33.7	11.7	28.0	23.4	44.5	44.0
AC019117.3		ENSG00000283321			7	17299295-17467234	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"cervix, uterine: 9.9;urinary bladder: 21.3"	"Cell line enriched"	"Detected in some"	5	"RT4: 34.3"									"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA029722	Uncertain									"HPA029722: AB_10599189"																		2.8	0.1	0.0	1.5	0.0	0.6	1.3	0.0	2.2	9.9	0.9	0.0	0.5	0.3	1.7	0.8	1.3	2.2	1.6	0.7	0.0		1.0	1.8	2.5	4.8	0.0	0.0	1.1	4.1	0.0	0.0	3.3	0.4	1.6	0.3	0.7	0.8	3.9	0.0	0.5	0.1	4.8	1.3	1.8	1.1	0.4	0.3	0.3	0.6	2.4	1.3	21.3	1.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.3	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	34.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.9	6.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
AC136352.3		ENSG00000277666			Unmapped	100123-101141	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in single"		"urinary bladder: 1.2"	"Cell line enhanced"	"Detected in some"		"RT4: 2.2;U-2 OS: 1.1"									"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA003342	Uncertain									"HPA003342: AB_1078588"																		0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.8	0.2	0.0			0.0	0.0	0.0		0.0		0.2	0.0		0.0	0.0	0.0	0.0	0.0	0.0		0.2	0.0	0.0			0.0		0.0	1.2		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
AC141272.1		ENSG00000277836			Unmapped	1270984-1271271	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"blood: 15.4;intestine: 16.4;lymphoid tissue: 22.4;urinary bladder: 14.5"	"Cell line enhanced"	"Detected in some"		"Daudi: 1.8;K-562: 2.1;RH-30: 1.7;RPMI-8226: 5.9;SCLC-21H: 1.6"									"Group enriched"	"Detected in some"	113	"memory B-cell: 15.4;naive B-cell: 7.0"	"Lineage enriched"	"Detected in single"	155	"B-cells: 15.4"																																					0.0	0.0		6.5		1.5	1.0		0.0	2.9	16.2			16.4	0.0	0.0	1.3	0.0	0.0	0.0			0.0	0.0	0.0	3.2			0.0	0.0	0.0		0.0		0.0	5.2		10.9	0.0	0.0	0.0	8.3	0.0		4.3	11.6	0.0			0.0		22.4	14.5		15.4	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	5.9	0.0	0.0	1.6	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.4	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6										
ACER2	"ALKCDase2, ASAH3L, FLJ41587"	ENSG00000177076	"Alkaline ceramidase 2"	Q5QJU3	9	19409059-19452020	"Enzymes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"stomach 1: 41.0;urinary bladder: 31.3;vagina: 40.6"	"Group enriched"	"Detected in many"	7	"BEWO: 16.4;RT4: 40.2"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 15.6"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 3.1"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"unprognostic (1.94e-1)"	"unprognostic (2.29e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.19e-1)"	"unprognostic (3.95e-2)"	"unprognostic (2.03e-1)"	"unprognostic (3.90e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.13e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.09e-1)"	"unprognostic (7.42e-2)"	"unprognostic (8.46e-3)"	17.4	1.7	3.1	0.7	5.9	0.4	20.7	2.3	6.8	1.4	3.5	0.9	5.3	3.0	1.3	3.0	1.8	2.8	1.3	3.2	3.0	1.9	1.6	2.6	1.5	0.6	4.4	0.3	1.3	4.7	2.7	1.6	20.0	4.5	9.4	3.1	1.4	1.8	6.8	2.1	4.0	1.7	2.1	2.9	1.2	41.0	1.3	4.7	0.4	1.8	1.0	0.8	31.3	40.6	1.0	1.2	0.0	3.1	0.0	1.0	0.5	0.6	1.2	2.0	1.1	3.5	0.2	16.4	1.0	0.7	0.4	0.5	0.3	1.0	0.7	0.4	0.1	2.4	0.5	3.2	0.9	1.3	0.6	1.1	0.9	1.5	0.7	0.2	1.0	1.1	3.0	1.2	1.4	3.4	1.7	2.0	1.1	0.9	1.9	0.9	1.5	0.5	1.6	0.6	0.4	0.3	40.2	3.8	0.9	0.2	1.0	0.2	1.4	1.4	1.7	0.3	0.8	0.3	0.5	0.7	0.9	0.8	0.3	0.8	0.7	0.0	0.1	0.0	0.8	3.1	0.2	1.0	0.3	0.3	0.3	0.4	1.0	0.2	0.0	0.0	0.0	1.2	0.3	0.5	3.1	5.9	2.3	6.8	3.0	1.9	4.4	0.3	4.5	4.7
ACTG2	"ACTA3, ACTL3, ACTSG"	ENSG00000163017	"Actin, gamma 2, smooth muscle, enteric"	P63267	2	73892314-73919865	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 404.6;smooth muscle: 581.1;urinary bladder: 568.2"	"Cell line enhanced"	"Detected in some"		"BEWO: 16.4;BJ hTERT+: 13.4;BJ hTERT+ SV40 Large T+: 53.0;HHSteC: 13.8;U-251 MG: 57.0"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 255.0;stomach cancer: 237.2"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	9	"T-reg: 10.9"	"Lineage enriched"	"Detected in single"	17	"T-cells: 10.9"	"Low region specificity"	"Detected in single"			"Region enriched"	"Detected in many"	6	"midbrain: 17.0"	"HPA041264, HPA041271"	Supported									"HPA041264: AB_2677383, HPA041271: AB_2677386"	"unprognostic (5.79e-3)"	"unprognostic (2.25e-1)"	"unprognostic (2.36e-2)"	"unprognostic (2.91e-1)"	"unprognostic (4.56e-3)"	"unprognostic (2.50e-1)"	"unprognostic (8.05e-2)"	"unprognostic (6.53e-2)"	"unprognostic (4.48e-2)"	"unprognostic (2.93e-1)"	"unprognostic (7.23e-2)"	"unprognostic (4.75e-2)"	"prognostic unfavourable (3.95e-7)"	"unprognostic (9.30e-3)"	"unprognostic (6.84e-2)"	"unprognostic (2.29e-2)"	"unprognostic (7.57e-3)"	8.7	1.2	0.3	57.4	0.4	0.0	6.8	0.3	0.4	90.0	404.6	0.8	187.4	15.9	188.2	76.1	348.3	45.5	122.5	5.6	0.3	0.3	2.9	0.6	7.0	3.6	0.4	0.6	25.9	1.1	0.0	0.4	10.0	0.9	160.8	52.4	2.8	9.4	271.2	2.4	4.7	80.2	581.1	0.4	0.9	134.9	14.5	0.1	0.1	1.8	2.0	2.3	568.2	35.2	0.2	0.5	0.4	0.6	0.2	10.9	2.3	0.1	0.0	5.4	0.0	0.0	0.0	16.4	3.5	13.4	53.0	9.9	1.7	0.0	0.0	0.2	0.0	0.0	9.5	0.0	7.6	0.0	0.0	0.0	0.8	0.1	13.8	0.0	0.1	0.1	0.0	7.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	2.1	0.0	0.0	0.0	0.1	0.8	0.1	3.5	0.1	0.6	0.0	0.7	0.3	0.0	0.0	0.0	0.3	0.6	0.6	57.0	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.5	0.4	0.4	0.4	0.2	0.2	1.1	0.4	0.5	0.2	0.6	0.7	0.2	0.2	0.6	0.2	10.9	2.3	0.3	0.4	0.3	0.4	0.3	0.3	0.4	0.6	0.9	0.1
ALG1L	ALG1L1	ENSG00000189366	"ALG1, chitobiosyldiphosphodolichol beta-mannosyltransferase like"	Q6GMV1	3	125929275-125937039	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"epididymis: 11.4;urinary bladder: 12.5"	"Cell line enhanced"	"Detected in some"		"CACO-2: 11.1;CAPAN-2: 10.1;HaCaT: 10.8;MCF7: 20.9;T-47d: 14.1;U-266/70: 7.9"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											HPA036108	Uncertain									"HPA036108: AB_10673344"	"unprognostic (7.06e-3)"	"unprognostic (1.50e-3)"	"unprognostic (1.47e-1)"	"unprognostic (4.14e-2)"	"prognostic favourable (3.00e-4)"	"unprognostic (2.40e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.47e-1)"	"unprognostic (4.37e-2)"	"unprognostic (5.79e-2)"	"unprognostic (4.50e-6)"	"unprognostic (1.35e-1)"	"unprognostic (3.30e-1)"	"unprognostic (1.57e-2)"	"prognostic favourable (6.24e-4)"	0.0	0.5	2.3	0.8	1.6	0.0	1.1	0.3	1.8	0.8	0.9			0.0	0.9	11.4	1.3	2.0	0.4	0.1	1.6	2.0	1.0	1.0	0.7	0.0	2.2		1.7	0.7	0.0	1.2	1.2		1.2	0.6		1.6	0.6	5.9	5.5	0.1	0.2	1.0	0.0	1.1	0.5			1.0		2.3	12.5	0.9	3.1	2.4	4.8	0.2	5.3	5.0	2.1	0.7	0.6	0.3	0.0	0.0	0.2	1.3	0.0	0.0	0.1	0.3	11.1	10.1	3.0	4.9	0.0	10.8	0.3	0.0	0.6	0.4	2.6	0.5	1.7	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.8	1.0	0.0	20.9	0.6	0.2	4.5	2.7	0.1	0.0	5.0	0.0	0.6	1.7	0.7	0.4	0.1	0.5	14.1	0.2	0.2	0.1	1.7	0.1	0.0	7.9	1.1	4.1	0.1	0.0	0.7	4.8	0.1	0.2	3.9	0.2	2.1	3.1	2.1	4.2	0.0	1.9	2.3	1.6	0.8	5.3	0.0	2.4	5.0	2.1										
ALKAL1	"AUGB, FAM150A, UNQ9433"	ENSG00000196711	"ALK and LTK ligand 1"	Q6UXT8	8	52534037-52565507	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"gallbladder: 8.7;prostate: 6.8;urinary bladder: 9.9"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 5.1;HMC-1: 1.5;NTERA-2: 1.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"olfactory region: 0.5"	"Low region specificity"	"Detected in all"			HPA027368	Uncertain				"Secreted - unknown location"					"HPA027368: AB_10602317"			"unprognostic (1.18e-1)"	"unprognostic (1.13e-4)"				"unprognostic (9.47e-2)"		"unprognostic (9.64e-2)"	"unprognostic (1.52e-1)"	"unprognostic (6.60e-2)"	"unprognostic (1.70e-4)"	"unprognostic (4.48e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.34e-1)"	"unprognostic (9.58e-3)"	0.0	0.0	0.3	1.6	0.2	0.0	0.0	0.0	0.4	3.2	3.0	0.0	0.0	1.5	0.1	0.0	3.9	0.6	8.7	0.0	0.1	0.2	0.3	1.1	1.0	0.0	0.2	0.0	0.0	0.8	0.0	0.0	0.3	0.2	6.8	0.3	0.0	2.4	0.0	0.0	0.2	2.2	4.6	0.2	0.0	1.0	0.4	0.3	0.3	6.0	0.0	0.0	9.9	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.4	0.1	0.2	0.2	0.0	0.2	0.3
BAG2		ENSG00000112208	"BCL2 associated athanogene 2"	O95816	6	57172326-57189833	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 67.0;urinary bladder: 51.0"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018862, HPA019918"	Enhanced		Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA018862: AB_2669957, HPA019918: AB_2670317"	"unprognostic (3.93e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.60e-1)"	"unprognostic (1.33e-1)"	"unprognostic (5.63e-2)"	"unprognostic (8.32e-3)"	"prognostic unfavourable (6.72e-6)"	"unprognostic (1.10e-1)"	"unprognostic (7.79e-5)"	"unprognostic (6.20e-3)"	"unprognostic (4.71e-2)"	"unprognostic (6.56e-2)"	"unprognostic (6.07e-3)"	"unprognostic (5.97e-3)"	"unprognostic (8.77e-2)"	"prognostic unfavourable (1.26e-4)"	"unprognostic (6.24e-3)"	3.4	3.5	3.7	8.7	2.8	1.2	4.6	4.1	3.4	18.4	24.5	0.8	14.8	1.9	29.4	9.5	13.4	5.9	6.9	17.2	3.3	3.5	3.7	3.8	4.1	2.3	3.3	2.3	15.4	1.5	0.6	4.5	6.7	3.4	23.7	4.3	2.6	1.5	15.1	9.9	1.7	5.7	67.0	3.4	1.3	7.4	6.7	2.6	1.6	7.6	6.0	1.9	51.0	17.1	5.9	1.4	0.9	0.4	3.3	6.1	1.9	9.3	5.2	2.2	7.8	5.5	15.9	6.2	15.2	14.5	11.0	10.5	6.7	4.8	3.1	14.6	24.0	1.7	12.6	1.3	10.6	9.9	9.3	9.1	7.8	15.1	8.5	8.0	2.1	7.7	0.7	9.0	8.5	8.5	18.4	4.5	10.8	0.7	5.6	6.7	8.4	5.4	5.2	6.2	6.3	13.1	1.5	2.8	2.5	6.8	0.5	5.5	1.2	7.0	11.6	6.3	10.3	13.2	15.0	3.0	2.9	6.9	5.6	3.2	0.6	0.1	0.3	0.9	3.3	0.4	3.9	5.9	3.1	3.3	1.4	4.3	6.1	5.1	0.3	3.3	0.1	0.5	3.2	1.9	3.7	2.8	4.1	3.4	3.3	3.5	3.3	2.3	3.4	2.6
BMP3		ENSG00000152785	"Bone morphogenetic protein 3"	P12645	4	81030965-81057531	"Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 15.0;lung: 21.0;urinary bladder: 18.7"	"Group enriched"	"Detected in some"	4	"AF22: 10.3;Daudi: 15.7;RT4: 13.1;SK-BR-3: 5.9"	"Cancer enhanced"	"Detected in some"		"urothelial cancer: 7.5"	"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"naive B-cell: 3.5"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"								"Secreted in other tissues"						"unprognostic (5.21e-3)"	"unprognostic (1.00e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.23e-2)"	"unprognostic (2.07e-1)"	"unprognostic (3.36e-2)"		"unprognostic (2.73e-3)"		"unprognostic (9.11e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.16e-4)"	"unprognostic (2.26e-2)"	"unprognostic (3.86e-1)"	"unprognostic (1.11e-1)"	"unprognostic (4.22e-2)"	2.4	0.5	1.4	3.8	0.6	0.8	4.5	0.8	0.7	0.9	15.0	0.0	0.3	3.5	0.2	0.3	4.2	1.1	2.5	0.2	0.7	1.0	0.3	0.2	21.0	0.5	0.3	0.4	3.0	1.0	0.0	0.4	0.0	0.5	3.7	7.9	2.9	6.9	0.0	0.6	0.7	11.2	1.5	0.9	0.2	2.2	0.3	0.0	0.0	0.3	1.6	2.3	18.7	10.5	3.5	0.0	0.6	0.1	1.2	0.1	0.2	0.0	0.0	10.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.7	0.0	0.0	1.9	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	13.1	0.1	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.7	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	3.5	0.1	0.0	0.5	1.2	0.0	0.0	0.0	0.2	1.4	0.6	0.8	0.7	0.7	1.0	0.3	0.4	0.5	0.0
CLEC3A	CLECSF1	ENSG00000166509	"C-type lectin domain family 3 member A"		16	78022515-78066761	"Predicted secreted proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"breast: 14.6;prostate: 8.6;smooth muscle: 17.1;urinary bladder: 17.2"	"Group enriched"	"Detected in some"	4	"SK-BR-3: 7.3;T-47d: 20.9"	"Cancer enriched"	"Detected in some"	102	"breast cancer: 78.5"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"midbrain: 0.5"	"Low region specificity"	"Detected in single"			HPA051511	Uncertain				"Secreted to extracellular matrix"					"HPA051511: AB_2681514"	"prognostic unfavourable (1.61e-4)"				"unprognostic (1.60e-1)"							"unprognostic (2.42e-1)"		"unprognostic (1.25e-1)"	"unprognostic (4.95e-2)"		"unprognostic (3.80e-2)"	0.1	0.1	0.1	1.8	0.3	0.0	14.6	0.1	0.8	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.1	4.6	0.3	0.1	1.1	0.1	0.1	0.5	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.4	8.6	0.0	3.3	0.1	0.0	0.1	0.1	0.1	17.1	0.1	0.1	0.8	0.1	0.0	0.0	0.1	1.9	0.0	17.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.3	0.0	20.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.8	0.1	1.1	0.1	0.0	0.4	0.0
CNN1	"Sm-Calp, SMCC"	ENSG00000130176	"Calponin 1"	P51911	19	11538717-11550323	"Cancer-related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 489.2;urinary bladder: 357.9"	"Cell line enhanced"	"Detected in some"		"BJ: 34.6;BJ hTERT+: 13.3;BJ hTERT+ SV40 Large T+: 18.1;BJ hTERT+ SV40 Large T+ RasG12V: 25.1;HBF TERT88: 28.0;K-562: 12.9;U-2 OS: 13.0"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 142.1"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB000007, HPA014263"	Enhanced		Approved	"Actin filaments"				"Actin filaments"	"Actin filaments"	"CAB000007: AB_2082148, HPA014263: AB_1847039"	"unprognostic (4.98e-3)"	"unprognostic (1.01e-1)"	"unprognostic (3.04e-3)"	"unprognostic (1.95e-1)"	"unprognostic (2.47e-1)"	"unprognostic (4.20e-1)"	"unprognostic (5.10e-3)"	"unprognostic (1.76e-1)"	"unprognostic (1.35e-1)"	"unprognostic (7.06e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.01e-1)"	"prognostic unfavourable (5.43e-6)"	"unprognostic (1.70e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.78e-3)"	"unprognostic (6.11e-3)"	9.3	4.1	0.5	34.9	0.9	0.0	7.9	0.5	1.2	90.5	193.4	1.3	78.1	9.4	182.6	50.6	140.5	52.2	105.7	22.2	0.6	0.6	6.2	1.0	9.5	2.2	0.7	1.8	36.5	1.3	0.0	0.7	4.0	2.2	120.1	26.4	8.8	9.1	125.2	4.8	4.5	37.1	489.2	1.0	1.2	66.5	16.4	0.5	0.4	3.2	4.5	3.3	357.9	26.8	0.0	0.4	0.0	0.1	0.0	0.0	5.2	0.0	0.5	2.2	0.4	0.2	0.0	1.4	34.6	13.3	18.1	25.1	9.8	0.0	0.1	1.0	9.8	0.1	0.0	0.0	28.0	0.0	0.0	0.0	0.0	0.8	0.9	0.0	0.1	1.2	0.0	11.1	0.0	0.0	12.9	0.0	0.0	0.0	0.1	1.7	1.1	0.2	0.1	0.4	1.3	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.1	0.1	13.0	0.5	0.4	0.0	0.1	0.0	1.2	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.5	0.9	0.5	1.2	0.6	0.6	0.7	1.8	2.2	0.5
CYP24A1	"CP24, CYP24, P450-CC24"	ENSG00000019186	"Cytochrome P450 family 24 subfamily A member 1"	Q07973	20	54153449-54173973	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 38.8;lymphoid tissue: 25.8;urinary bladder: 31.2"	"Group enriched"	"Detected in some"	16	"A549: 92.9;Hep G2: 27.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"memory CD4 T-cell: 1.1;memory CD8 T-cell: 2.0"	"Lineage enriched"	"Detected in single"	20	"T-cells: 2.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA022261, HPA063771"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Mitochondria"				"Nucleoplasm, Mitochondria"	"Nucleoplasm, Mitochondria"	"HPA022261: AB_1847427, HPA063771: AB_2685120"	"unprognostic (1.19e-7)"	"unprognostic (1.73e-1)"	"unprognostic (2.24e-2)"	"unprognostic (7.69e-3)"	"unprognostic (3.30e-1)"	"unprognostic (2.30e-2)"		"unprognostic (1.11e-2)"	"unprognostic (2.12e-1)"	"unprognostic (2.09e-2)"	"unprognostic (5.37e-3)"	"unprognostic (1.23e-1)"	"unprognostic (6.05e-2)"	"unprognostic (5.98e-2)"	"unprognostic (1.36e-1)"	"unprognostic (4.38e-2)"	"unprognostic (2.12e-1)"	0.1	0.1	0.4	0.2	0.7	0.0	2.5	0.1	0.4	2.5	0.1	0.0	0.3	0.0	11.2	0.4	4.4	0.3	0.0	0.1	0.4	0.8	38.8	0.3	1.6	0.1	0.2	0.0	0.1	0.1	0.0	0.7	7.0	0.3	7.0	0.0	0.1	0.3	1.5	0.1	1.0	0.1	0.6	0.2	0.1	0.1	0.3	0.0	0.4	1.4	5.9	25.8	31.2	14.4	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.1	92.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	2.8	0.0	0.7	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	1.3	27.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	1.5	0.3	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.1	2.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.7	0.1	0.4	0.4	0.8	0.2	0.0	0.3	0.0
DHRS2	"HEP27, SDR25C1"	ENSG00000100867	"Dehydrogenase/reductase 2"	Q13268	14	23630115-23645639	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"breast: 79.9;prostate: 40.2;urinary bladder: 120.7;vagina: 47.1"	"Cell line enhanced"	"Detected in some"		"Hep G2: 48.8;RT4: 58.4;SK-BR-3: 285.8;U-2 OS: 93.6"	"Cancer enriched"	"Detected in many"	6	"urothelial cancer: 141.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	4	"cerebellum: 2.7"					"HPA053915, HPA069551"	Enhanced		Supported	Nucleoplasm,Mitochondria				Mitochondria	Mitochondria	"HPA053915: AB_2682307, HPA069551: AB_2686150"	"unprognostic (3.07e-1)"	"unprognostic (4.91e-2)"	"unprognostic (3.44e-2)"	"prognostic unfavourable (3.23e-4)"	"unprognostic (9.97e-2)"	"unprognostic (5.03e-3)"	"unprognostic (5.62e-2)"	"unprognostic (1.86e-1)"	"unprognostic (4.08e-1)"	"unprognostic (6.91e-2)"	"unprognostic (6.66e-2)"	"unprognostic (4.59e-2)"	"prognostic unfavourable (3.75e-5)"	"unprognostic (1.83e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.76e-1)"	"prognostic favourable (6.45e-4)"	0.1	0.3	0.3	0.0	0.2	0.0	79.9	0.1	0.2	0.5	0.1	0.1	0.3	0.0	0.1	0.2	0.1	0.1	0.0	0.1	0.3	0.8	1.8	5.0	0.2	0.0	0.2	0.0	9.0	5.9	0.3	0.5	5.0	0.1	40.2	0.0	0.1	20.1	0.6	0.1	0.7	0.1	23.1	0.3	3.7	0.8	0.9	0.0	0.0	0.1	0.0	0.0	120.7	47.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	14.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.9	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	19.7	1.5	0.1	0.0	48.8	0.0	0.2	1.7	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.5	0.1	0.0	0.0	2.2	0.1	0.4	0.1	0.0	58.4	0.2	0.3	0.4	285.8	0.3	0.2	0.0	0.0	0.1	93.6	0.5	0.2	0.1	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.1	0.2	0.3	0.8	0.2	0.0	0.1	0.0
EVX1		ENSG00000106038	"Even-skipped homeobox 1"	P49640	7	27242700-27250493	"Predicted intracellular proteins, Transcription factors"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"adrenal gland: 6.5;prostate: 6.4;seminal vesicle: 6.7;urinary bladder: 8.9"	"Cell line enriched"	"Detected in some"	12	"RT4: 17.8"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in single"	26	"pons and medulla: 3.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	15	"midbrain: 1.0;pons and medulla: 1.0"	"Region enriched"	"Detected in single"	9	"pons and medulla: 1.1"	HPA055132			Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA055132: AB_2682707"	"unprognostic (2.73e-2)"	"unprognostic (3.59e-1)"	"unprognostic (4.31e-1)"		"unprognostic (5.16e-2)"		"unprognostic (1.76e-3)"	"unprognostic (2.08e-2)"			"unprognostic (8.48e-3)"	"unprognostic (5.94e-2)"	"unprognostic (1.26e-8)"	"unprognostic (2.94e-1)"	"unprognostic (1.39e-1)"	"unprognostic (9.12e-2)"	"unprognostic (1.83e-2)"	0.1	6.5	0.1	0.1	0.1	0.0	0.1	0.1	0.1	4.2	0.6	0.1	0.1	0.0	0.9	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	1.5	3.0	6.4	0.7	0.1	0.1	6.7	0.1	0.0	0.1	1.9	0.1	0.1	0.0	1.7	0.1	0.1	0.1	0.1	0.1	8.9	5.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	17.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	3.0	0.1
FAM129A	"C1orf24, GIG39, NIBAN"	ENSG00000135842	"Family with sequence similarity 129 member A"	Q9BZQ8	1	184790724-184974550	"Cancer-related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 129.1;urinary bladder: 90.3"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	5	"neutrophil: 32.7"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 32.7"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA028172, HPA028231, HPA028657"	Approved		Supported	"Plasma membrane,Cytosol"		40000	40000	"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"HPA028172: AB_10599602, HPA028231: AB_10601886, HPA028657: AB_10601680"	"unprognostic (4.61e-3)"	"unprognostic (3.45e-2)"	"unprognostic (1.64e-3)"	"unprognostic (9.46e-2)"	"unprognostic (2.77e-1)"	"unprognostic (3.87e-1)"	"unprognostic (3.23e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.68e-1)"	"unprognostic (6.32e-2)"	"unprognostic (4.12e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.94e-3)"	"unprognostic (9.01e-3)"	"unprognostic (4.38e-2)"	"unprognostic (3.73e-2)"	"prognostic unfavourable (4.52e-4)"	10.1	3.5	1.1	16.9	1.8	2.3	7.8	0.8	1.3	13.0	39.3	1.0	14.9	2.5	14.6	11.0	32.3	10.7	30.4	52.2	1.1	1.1	1.8	1.2	6.1	10.7	3.0	0.5	8.0	27.3	0.8	1.9	2.9	1.7	34.6	5.1	13.8	59.3	14.7	21.4	4.1	8.3	129.1	2.1	6.5	30.0	4.1	1.3	4.9	4.7	14.7	8.7	90.3	20.3	0.5	2.3	32.7	1.5	2.6	5.3	0.8	13.6	0.1	0.0	0.0	9.8	14.9	0.5	7.0	14.4	6.1	7.7	0.0	5.8	0.0	4.6	18.0	15.4	0.8	0.5	9.8	27.2	1.1	5.7	2.9	0.0	22.8	18.5	6.5	13.6	22.3	17.7	21.5	0.0	1.3	28.9	0.1	0.0	0.6	3.2	3.7	1.4	4.3	3.3	0.2	8.4	0.2	0.7	0.7	0.1	0.0	10.0	3.0	5.9	1.1	12.1	0.0	2.1	14.4	24.3	9.6	2.9	23.7	7.7	11.8	7.1	1.5	4.7	2.5	0.9	2.1	0.5	2.2	2.3	2.3	0.1	0.2	0.9	32.7	2.6	0.3	0.2	5.3	0.8	1.1	1.8	0.8	1.3	1.1	1.1	3.0	0.5	1.7	1.3
FGF23		ENSG00000118972	"Fibroblast growth factor 23"	Q9GZV9	12	4368227-4379728	"Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins, RAS pathway related proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 11.1;heart muscle: 9.1;liver: 10.1;urinary bladder: 6.7"	"Cell line enhanced"	"Detected in many"		"AF22: 5.4;HBEC3-KT: 3.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"								"Secreted to blood"									"unprognostic (1.31e-1)"						"unprognostic (2.18e-2)"				"unprognostic (1.44e-1)"	"unprognostic (1.67e-1)"			0.3	0.4	0.2	0.2	0.2	0.8	0.2	0.2	0.8	0.2	0.2	0.2	0.2	0.4	0.5	3.5	1.2	0.5	0.2	9.1	0.2	0.2	0.3	10.1	0.3	2.6	0.2	0.2	0.3	0.2	0.1	0.4	0.3	0.2	0.2	1.4	0.2	1.0	0.2	2.5	0.4	0.3	0.7	0.2	1.1	0.2	0.9	0.2	0.6	0.3	0.2	1.3	6.7	0.2	3.1	2.9	11.1	3.6	3.4	3.1	1.7	0.2	0.0	5.4	1.8	2.8	0.6	0.8	0.1	0.1	0.0	0.2	1.0	1.9	0.3	0.2	0.9	1.2	0.8	3.9	0.2	0.2	0.6	0.2	0.7	0.6	1.6	1.1	0.5	1.6	0.1	2.5	3.2	0.4	0.5	2.3	0.1	0.0	0.7	1.3	1.4	0.2	0.9	0.1	0.8	0.6	1.1	1.2	1.1	0.0	1.8	0.2	1.3	0.8	0.0	2.0	0.5	1.4	0.3	0.1	0.2	0.3	1.2	0.4	1.3	11.1	2.3	2.9	2.6	2.4	3.1	2.9	2.5	2.0	1.8	3.1	2.8	2.9	7.2	3.4	3.6	2.9	2.3	1.7	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2
FLNA	"ABP-280, FLN, FLN1, OPD1, OPD2"	ENSG00000196924	"Filamin A"	P21333	X	154348524-154374638	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"smooth muscle: 396.7;urinary bladder: 276.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB000356, HPA000368, HPA001016, HPA001115, HPA002925"	Enhanced	Approved	Enhanced	"Plasma membrane,Actin filaments,Cytosol"		2900000000	2900000000	"Plasma membrane, Actin filaments, Cytosol"	"Plasma membrane, Actin filaments, Cytosol"	"CAB000356: , HPA000368: AB_2797215, HPA001016: , HPA001115: AB_1078871, HPA002925: AB_1078869"	"unprognostic (1.39e-1)"	"unprognostic (9.40e-3)"	"prognostic unfavourable (7.37e-4)"	"unprognostic (3.68e-2)"	"unprognostic (2.55e-1)"	"unprognostic (6.05e-3)"	"unprognostic (5.08e-2)"	"unprognostic (1.08e-1)"	"unprognostic (6.02e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.23e-2)"	"unprognostic (9.58e-2)"	"prognostic unfavourable (1.54e-6)"	"unprognostic (5.49e-3)"	"unprognostic (1.78e-1)"	"unprognostic (1.62e-1)"	"prognostic unfavourable (3.88e-4)"	42.8	8.8	2.9	46.4	3.9	22.9	30.7	2.0	5.2	106.5	204.2	6.3	86.0	13.1	158.9	54.4	140.2	79.9	121.0	18.8	3.2	2.2	17.2	5.5	29.1	21.1	3.4	5.9	77.4	7.3	1.6	4.8	20.0	9.4	129.3	13.4	19.0	12.6	98.8	13.7	15.0	50.2	396.7	3.6	25.5	82.7	29.9	2.9	12.1	11.7	16.3	15.1	276.1	64.5	6.3	13.1	7.1	19.7	5.9	22.6	24.1	87.2	67.8	23.9	30.8	20.9	27.7	39.4	58.4	65.1	53.6	47.7	43.9	16.2	7.5	151.6	90.7	50.1	21.5	51.2	15.1	30.8	7.5	24.2	88.7	15.2	38.5	28.6	31.8	26.5	12.4	79.8	31.9	39.8	6.8	52.3	38.3	20.0	13.6	9.9	25.2	45.1	13.7	21.7	6.7	20.8	18.2	5.3	12.1	48.8	7.9	39.3	7.6	9.0	95.2	61.2	59.0	62.0	107.6	32.8	19.2	15.2	56.9	19.2	61.2	4.1	11.5	7.1	22.6	15.2	14.3	6.3	10.5	18.7	13.1	3.0	4.0	9.1	2.6	5.9	19.7	1.7	12.8	24.1	2.9	3.9	2.0	5.2	3.2	2.2	3.4	5.9	9.4	2.9
FOXF1	"FKHL5, FREAC1"	ENSG00000103241	"Forkhead box F1"	Q12946	16	86510527-86515418	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 54.7;urinary bladder: 48.5"	"Group enriched"	"Detected in some"	4	"BJ: 9.2;BJ hTERT+: 20.2;HHSteC: 19.9;U-2197: 8.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA028886			Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA028886: AB_10601652"	"unprognostic (7.91e-2)"	"unprognostic (3.02e-3)"	"unprognostic (1.23e-1)"	"unprognostic (4.38e-2)"	"unprognostic (1.84e-2)"	"unprognostic (2.62e-3)"	"unprognostic (2.37e-2)"	"unprognostic (1.08e-1)"	"unprognostic (8.22e-2)"	"unprognostic (6.07e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.91e-2)"	"unprognostic (1.29e-2)"	"unprognostic (4.89e-2)"	"unprognostic (4.20e-2)"	"unprognostic (7.11e-2)"	"unprognostic (2.44e-1)"	2.2	0.3	2.5	15.4	2.9	0.0	0.8	2.3	4.2	7.9	34.6	1.3	1.6	7.2	2.1	0.9	17.9	1.2	39.7	0.6	3.4	1.9	1.2	2.4	33.1	2.4	3.5	1.0	0.6	0.9	1.1	0.4	18.5	3.5	35.7	9.2	0.5	0.9	4.8	0.3	0.4	18.4	54.7	3.0	0.5	18.4	0.6	3.7	0.0	3.6	2.6	3.3	48.5	25.4	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.2	20.2	2.8	0.9	0.0	0.1	0.0	0.0	0.8	0.0	1.6	0.0	2.4	0.0	1.1	0.0	1.4	0.0	19.9	0.0	1.7	2.1	0.0	3.3	0.4	3.4	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	3.0	0.6	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	1.4	8.7	0.0	0.0	0.0	0.0	1.8	0.1	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	2.5	2.9	2.3	4.2	3.4	1.9	3.5	1.0	3.5	3.7
FOXP2	"CAGH44, SPCH1, TNRC10"	ENSG00000128573	"Forkhead box P2"	O15409	7	114086327-114693772	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 48.4;urinary bladder: 31.5"	"Cell line enhanced"	"Detected in many"		"AF22: 14.7;RH-30: 27.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA000382, HPA000383, HPA001679"	Enhanced		Enhanced	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA000382: AB_1078908, HPA000383: AB_1078909, HPA001679: AB_2666415"	"unprognostic (1.21e-1)"	"unprognostic (7.85e-2)"	"unprognostic (4.89e-2)"	"unprognostic (8.83e-3)"	"unprognostic (4.66e-1)"	"unprognostic (3.69e-4)"	"unprognostic (2.04e-2)"	"unprognostic (6.22e-2)"	"unprognostic (2.17e-1)"	"unprognostic (6.70e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.77e-1)"	"unprognostic (8.04e-2)"	"unprognostic (4.16e-3)"	"unprognostic (2.84e-1)"	"unprognostic (9.81e-2)"	"unprognostic (4.19e-2)"	1.7	1.5	0.9	9.4	2.9	0.0	2.0	0.6	2.8	9.4	20.4	0.7	3.6	2.7	18.1	2.1	12.4	3.5	7.7	1.2	0.7	2.9	1.5	2.9	1.4	0.6	2.0	1.0	11.1	4.5	0.0	0.9	0.7	1.8	13.3	5.7	1.4	2.8	1.5	4.6	3.3	4.2	48.4	0.9	0.6	4.6	0.9	0.9	0.6	5.3	3.2	1.2	31.5	5.4	9.4	16.5	11.1	7.2	6.3	10.3	16.3	0.2	2.1	14.7	0.0	3.4	4.6	0.9	2.3	2.5	0.5	0.3	1.0	0.2	0.2	0.5	0.8	0.3	0.5	0.0	0.1	0.1	5.0	5.5	3.3	4.5	0.0	0.3	0.3	1.1	0.6	0.0	0.0	0.6	1.2	2.1	0.5	1.0	1.2	0.8	0.7	0.7	0.3	27.0	5.2	0.3	5.9	3.8	1.5	0.0	0.9	0.7	0.7	8.0	1.1	0.9	0.4	1.4	0.4	5.3	0.4	0.5	1.1	0.5	0.4	7.5	5.2	11.1	6.2	7.2	6.3	9.4	7.0	6.8	6.8	7.3	7.2	8.1	5.6	6.3	5.9	16.5	10.3	16.3	0.9	2.9	0.6	2.7	0.7	2.9	2.0	1.0	1.8	0.9
HAS3		ENSG00000103044	"Hyaluronan synthase 3"	O00219	16	69105564-69118719	"Enzymes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 22.6;urinary bladder: 22.9"	"Cell line enhanced"	"Detected in some"		"HaCaT: 14.1;PC-3: 75.1;RT4: 29.7"	"Group enriched"	"Detected in many"	8	"cervical cancer: 17.1;head and neck cancer: 44.9;lung cancer: 23.3;urothelial cancer: 31.1"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA031554, CAB033850"	Supported		Approved	Microtubules				Microtubules	Microtubules	"CAB033850: AB_2116418, HPA031554: AB_10670703"	"unprognostic (3.26e-2)"	"unprognostic (1.22e-1)"	"unprognostic (5.12e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.16e-1)"	"unprognostic (7.59e-3)"	"unprognostic (2.86e-3)"	"unprognostic (1.84e-1)"	"unprognostic (3.70e-1)"	"unprognostic (1.77e-1)"	"prognostic unfavourable (5.36e-4)"	"unprognostic (2.46e-1)"	"unprognostic (3.27e-3)"	"unprognostic (3.25e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.21e-2)"	"unprognostic (3.40e-3)"	0.4	0.2	0.4	0.4	1.0	0.3	5.5	1.1	1.3	3.3	3.7	0.4	0.4	1.9	0.8	1.1	22.6	0.7	3.5	2.4	0.6	0.6	1.2	0.7	18.0	0.4	0.4	0.4	0.9	2.2	0.1	1.0	3.3	1.1	3.5	2.3	0.6	7.6	2.1	0.6	5.7	2.1	1.4	0.4	0.4	9.0	2.0	0.4	0.5	4.0	11.7	11.1	22.9	13.6	1.5	1.2	2.2	1.4	0.4	2.0	1.1	0.9	4.7	0.2	0.2	0.1	0.1	1.8	0.3	0.1	0.2	0.1	1.0	2.4	0.2	0.5	0.1	14.1	0.7	8.4	0.2	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.2	0.1	2.3	0.3	0.8	0.1	0.0	0.1	0.0	0.5	0.3	0.1	4.2	75.1	0.5	0.0	0.0	7.7	29.7	5.3	0.2	0.5	0.0	0.0	0.2	0.2	0.1	0.2	0.2	8.2	0.4	0.3	0.2	0.0	0.3	0.0	0.1	0.8	1.4	2.2	1.4	0.7	1.3	0.7	1.1	0.5	1.2	1.5	2.0	0.7	0.5	0.4	1.1	1.0	1.5	1.1	0.4	1.0	1.1	1.3	0.6	0.6	0.4	0.4	1.1	0.4
HOXA1	"HOX1, HOX1F"	ENSG00000105991	"Homeobox A1"	P49639	7	27092993-27095996	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"urinary bladder: 12.9"	"Cell line enhanced"	"Detected in many"		"HEK 293: 12.5;HMC-1: 12.7"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	10	"pons and medulla: 5.0"	"Group enriched"	"Detected in many"	5	"intermediate monocyte: 6.0;NK-cell: 6.8;non-classical monocyte: 8.7"	"Group enriched"	"Detected in many"	6	"monocytes: 8.7;NK-cells: 6.8"	"Region enriched"	"Detected in single"	7	"pons and medulla: 1.0"	"Group enriched"	"Detected in some"	5	"midbrain: 1.3;pons and medulla: 1.9"												"unprognostic (7.39e-2)"	"unprognostic (1.26e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.17e-4)"	"unprognostic (2.79e-2)"	"prognostic unfavourable (6.73e-5)"	"unprognostic (4.70e-2)"	"unprognostic (2.72e-2)"	"unprognostic (6.65e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.06e-4)"	"unprognostic (2.03e-1)"	"unprognostic (2.82e-1)"	"unprognostic (5.77e-3)"	"unprognostic (1.17e-1)"	1.5	1.2	0.2	3.7	0.4	0.4	2.9	0.2	0.3	1.1	1.9	0.4	0.0	0.4	1.2	3.6	8.2	2.2	2.9	0.9	0.2	0.2	2.9	0.5	0.8	2.1	0.4	0.0	3.8	0.4	3.2	0.3	0.9	5.0	3.7	1.9	0.3	0.3	5.3	0.7	4.1	3.0	2.6	4.9	8.0	1.2	0.8	0.0	3.1	0.4	1.3	5.2	12.9	10.6	0.4	1.2	1.0	8.7	6.8	1.3	0.6	5.3	2.3	0.2	3.1	0.0	0.0	5.0	0.7	3.2	2.1	2.5	12.1	3.4	3.7	7.3	1.9	11.8	4.2	3.5	1.5	0.3	12.5	4.9	0.2	0.1	0.6	4.1	12.7	2.3	3.5	2.4	5.0	3.1	5.2	0.0	4.1	0.1	0.0	6.6	0.0	0.5	4.7	1.4	0.0	6.9	5.2	0.4	0.0	2.7	0.0	3.2	0.0	1.9	2.3	0.5	4.9	3.7	0.9	0.0	0.0	1.7	1.9	7.2	5.2	1.0	0.3	0.6	1.2	6.0	1.2	0.4	1.3	1.2	1.2	0.0	0.6	1.2	0.3	6.8	8.7	0.0	1.2	0.6	0.2	0.4	0.2	0.3	0.2	0.2	0.4	0.0	5.0	0.0
HOXB1	"HOX2, HOX2I"	ENSG00000120094	"Homeobox B1"	P14653	17	48528526-48531001	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"esophagus: 2.2;testis: 1.9;urinary bladder: 1.5"	"Cell line enhanced"	"Detected in single"		"T-47d: 1.9"	"Cancer enriched"	"Detected in single"	15	"testis cancer: 3.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA044576	Uncertain									"HPA044576: AB_10794501"	"unprognostic (1.80e-2)"	"unprognostic (9.50e-3)"		"unprognostic (8.22e-2)"		"unprognostic (1.22e-1)"		"unprognostic (6.26e-2)"		"unprognostic (2.40e-2)"	"unprognostic (1.03e-1)"			"unprognostic (1.96e-1)"	"unprognostic (6.74e-2)"		"unprognostic (1.45e-2)"	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.8	0.1	0.1	0.1	0.0	0.1	0.1	2.2	0.8	0.1	0.1	0.1	0.0	0.9	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.8	0.1	0.1	0.1	0.1	0.0	1.9	0.1	0.1	0.1	0.1	0.1	1.5	0.9	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.2	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
IFNE	IFNE1	ENSG00000184995	"Interferon epsilon"	Q86WN2	9	21480839-21482313	"Predicted secreted proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"epididymis: 3.9;urinary bladder: 4.1"	"Cell line enhanced"	"Detected in some"		"BJ: 4.7;HeLa: 12.3"	"Low cancer specificity"	"Detected in some"							"Cell type enriched"	"Detected in single"	10	"intermediate monocyte: 1.0"	"Lineage enriched"	"Detected in single"	10	"monocytes: 1.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"								"Secreted to blood"						"unprognostic (1.52e-3)"	"unprognostic (8.36e-2)"	"unprognostic (5.44e-2)"	"unprognostic (1.56e-5)"	"unprognostic (2.70e-1)"	"unprognostic (2.25e-1)"		"unprognostic (5.14e-3)"	"unprognostic (6.32e-1)"	"unprognostic (2.68e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.43e-2)"	"unprognostic (9.63e-3)"	"unprognostic (1.04e-1)"	"unprognostic (3.27e-2)"	"unprognostic (6.58e-3)"	"unprognostic (3.34e-2)"	0.1	0.0	0.0	0.1	0.0	0.0	0.6	2.6	0.2	1.3	0.0			1.4	0.3	3.9	3.3	1.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0		0.0	0.0	0.0	1.2	0.0		1.4	0.0		0.1	0.8	0.0	0.0	2.4	0.0	0.0	0.1	1.5	0.0			0.6		0.7	4.1	1.7	0.0	0.0	0.0	1.0	0.0	0.0	0.0	1.6	2.8	0.0	0.0	1.4	1.4	0.2	4.7	0.3	0.2	0.3	0.1	3.1	0.0	1.0	0.9	1.7	0.0	3.0	0.5	0.0	0.0	0.0	12.3	0.0	0.8	0.0	0.0	1.3	0.6	1.9	2.7	0.9	0.0	0.0	1.9	0.0	0.0	0.0	0.1	2.4	0.0	0.0	0.0	3.5	0.0	0.1	0.0	1.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
IL22	"IL-21, IL-22, IL-D110, IL-TIF, ILTIF, MGC79382, MGC79384, TIFa, TIFIL-23, zcyto18"	ENSG00000127318	"Interleukin 22"	Q9GZX6	12	68248242-68253607	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 2.8;urinary bladder: 3.6"	"Cell line enhanced"	"Detected in single"		"hTERT-HME1: 1.6"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"								"Secreted to blood"								"unprognostic (2.57e-1)"											"unprognostic (4.24e-2)"				0.2	0.0	0.0	2.8	0.0	0.1	0.0	1.0	0.0	0.0	0.2			0.5	0.0	0.0	1.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.5	0.0	0.0	0.0	1.5	0.8	0.0	0.1	0.0	0.7			0.0		0.6	3.6	0.2	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0										
IL26	"AK155, IL-26"	ENSG00000111536	"Interleukin 26"	Q9NPH9	12	68201351-68225821	"Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 6.0;tongue: 5.4;urinary bladder: 4.4"	"Cell line enriched"	"Detected in some"	14	"HDLM-2: 16.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	6	"MAIT T-cell: 2.2;memory CD4 T-cell: 1.5;memory CD8 T-cell: 1.1;T-reg: 1.1"	"Lineage enriched"	"Detected in single"	10	"T-cells: 2.2"					"Low region specificity"	"Detected in all"								"Secreted to blood"							"unprognostic (2.71e-1)"	"unprognostic (8.87e-2)"			"unprognostic (3.26e-5)"		"unprognostic (7.10e-2)"	"unprognostic (5.90e-2)"		"unprognostic (2.96e-1)"		"unprognostic (3.69e-5)"	"unprognostic (3.80e-1)"	"unprognostic (5.08e-2)"	"unprognostic (1.12e-3)"	"unprognostic (1.79e-2)"	0.1	0.0	0.5	6.0	0.2	0.0	0.0	0.7	0.1	0.1	1.0	0.0	0.0	0.2	0.0	0.0	1.4	0.1	0.5	0.3	1.0	0.2	0.1	0.1	0.5	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	2.3	0.0	0.0	0.5	1.4	0.0	0.1	1.1	0.3	0.3	0.0	0.5	0.1	5.4	3.5	4.4	0.3	0.2	0.0	0.0	0.0	0.0	2.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	16.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.2	0.2	1.5	1.1	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	1.1	0.1	0.5	0.2	0.7	0.1	1.0	0.2	0.1	0.0	0.0	0.0
IL9R	CD129	ENSG00000124334	"Interleukin 9 receptor"	Q01113	X	155997581-156010817	"CD markers, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"blood: 6.3;urinary bladder: 10.9"	"Cell line enriched"	"Detected in some"	11	"HMC-1: 74.2"	"Cancer enhanced"	"Detected in some"		"urothelial cancer: 1.4"	"Group enriched"	"Detected in some"	6	"basal ganglia: 1.7;pons and medulla: 4.7;thalamus: 1.5"	"Cell type enhanced"	"Detected in many"		"eosinophil: 6.3"	"Group enriched"	"Detected in many"	25	"B-cells: 4.1;granulocytes: 6.3;T-cells: 2.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA063240, HPA064557"	Approved				"Intracellular and membrane"					"HPA063240: AB_2732700, HPA064557: AB_2732716"	"unprognostic (1.07e-2)"	"unprognostic (3.27e-3)"	"unprognostic (9.52e-3)"	"unprognostic (4.13e-2)"	"unprognostic (7.35e-2)"	"unprognostic (3.26e-4)"	"unprognostic (8.94e-2)"	"unprognostic (3.56e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.82e-1)"	"unprognostic (2.90e-2)"	"unprognostic (2.04e-1)"	"unprognostic (3.98e-8)"	"unprognostic (2.06e-1)"	"unprognostic (2.38e-1)"	"unprognostic (4.07e-1)"	"prognostic favourable (1.90e-7)"	0.3	0.1	0.3	1.1	1.7	0.4	0.3	0.4	0.3	0.3	0.3	0.3	0.3	0.7	3.0	0.3	0.5	0.4	0.9	0.3	0.3	0.2	0.3	0.5	1.3	3.2	0.3	0.3	0.3	0.3	0.0	0.3	0.3	4.7	0.4	1.2	0.3	0.4	0.3	0.3	0.4	2.4	0.3	0.3	3.5	0.8	0.3	1.5	0.3	0.4	0.3	2.9	10.9	0.3	4.1	0.0	6.3	0.0	0.1	2.4	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	6.8	0.0	0.0	0.0	0.1	74.2	0.0	0.0	0.0	0.0	0.0	1.0	0.2	0.0	0.3	2.6	1.3	0.0	0.0	0.1	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.2	0.0	0.1	0.0	0.0	0.0	6.3	0.0	0.0	0.0	1.8	0.8	1.3	0.0	4.1	0.0	0.0	1.8	0.1	0.0	0.0	2.4	0.3	0.3	1.7	0.4	0.3	0.3	0.2	0.3	0.3	4.7	1.5
KRTAP22-1	KAP22.1	ENSG00000186924	"Keratin associated protein 22-1"	Q3MIV0	21	30601087-30601382	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in single"		"urinary bladder: 1.2"	"Cell line enriched"	"Detected in single"	22	"K-562: 2.2"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.6	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0		0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
KRTAP5-9	"KRN1, KRTAP5-1, KRTAP5.9"	ENSG00000254997	"Keratin associated protein 5-9"	P26371	11	71548418-71549553	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"epididymis: 5.1;testis: 4.6;urinary bladder: 4.6"	"Cell line enriched"	"Detected in single"	20	"RT4: 14.1"	"Cancer enhanced"	"Detected in some"		"urothelial cancer: 2.0"					"Cell type enriched"	"Detected in single"	11	"myeloid DC: 1.0"	"Lineage enriched"	"Detected in single"	11	"dendritic cells: 1.0"																				"unprognostic (1.72e-3)"	"unprognostic (2.20e-1)"	"unprognostic (2.22e-2)"	"unprognostic (2.16e-1)"	"unprognostic (4.13e-1)"	"unprognostic (6.53e-2)"	"unprognostic (8.10e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.06e-1)"	"unprognostic (7.76e-2)"	"unprognostic (7.23e-2)"	"unprognostic (2.56e-1)"	"unprognostic (3.29e-1)"	"unprognostic (2.05e-2)"	"unprognostic (2.01e-1)"	"unprognostic (4.82e-4)"	"prognostic favourable (9.25e-4)"	0.4	0.4	1.1	0.1	2.8	0.5	0.5	1.3	1.3	0.1	0.9			0.3	0.1	5.1	0.5	0.8	0.9	0.1	1.0	2.0	0.4	0.8	0.3	0.3	0.8		0.2	0.0	1.5	1.1	0.2		0.9	0.7		0.8	1.4	0.4	1.4	0.7	0.1	1.0	0.7	0.4	4.6			0.4		0.4	4.6	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.4	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.1	0.2	0.2	0.6	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.6	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.0	14.1	0.0	0.1	0.2	0.0	0.0	0.0	0.4	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
LMOD1	"1D, 64kD, D1"	ENSG00000163431	"Leiomodin 1"	P29536	1	201896452-201946588	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 199.7;urinary bladder: 165.5"	"Group enriched"	"Detected in some"	10	"ASC diff: 11.1;BJ: 14.3;BJ hTERT+: 23.3;fHDF/TERT166: 11.5;HSkMC: 10.2"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 43.9"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA028325, HPA028435, HPA030097"	Enhanced		Approved	Cytosol				Cytosol	Cytosol	"HPA028325: AB_10600300, HPA028435: AB_10602180, HPA030097: AB_10601223"	"unprognostic (3.84e-2)"	"unprognostic (5.01e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.64e-1)"	"unprognostic (6.35e-2)"	"prognostic favourable (2.52e-5)"	"unprognostic (1.27e-1)"	"unprognostic (6.10e-2)"	"unprognostic (1.73e-2)"	"unprognostic (3.51e-1)"	"unprognostic (1.05e-1)"	"prognostic unfavourable (1.05e-4)"	"unprognostic (4.30e-2)"	"unprognostic (2.72e-1)"	"unprognostic (4.44e-3)"	"unprognostic (1.15e-2)"	27.4	12.7	1.9	26.7	6.2	0.0	20.5	2.2	1.9	65.6	83.5	1.8	42.7	6.0	84.9	29.0	94.6	33.2	80.7	8.3	1.6	1.6	5.3	1.0	11.0	5.5	2.3	3.2	38.1	1.6	7.4	1.3	10.2	4.1	77.1	12.0	28.9	6.8	63.8	29.5	7.4	20.9	199.7	1.8	6.3	47.0	23.3	0.7	0.0	7.9	12.3	2.7	165.5	39.7	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.8	11.1	1.4	0.9	14.3	23.3	0.9	1.1	0.0	0.1	0.0	0.5	11.5	0.2	0.3	0.0	0.3	0.0	1.0	0.0	0.0	0.0	1.0	0.0	0.0	10.2	0.0	0.6	0.0	0.0	0.1	0.1	0.5	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.3	0.0	0.3	0.0	0.2	0.0	0.3	0.3	0.5	0.0	0.0	0.1	0.5	0.2	0.0	0.5	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	1.9	6.2	2.2	1.9	1.6	1.6	2.3	3.2	4.1	0.7
LPP		ENSG00000145012	"LIM domain containing preferred translocation partner in lipoma"	Q93052	3	188153284-188890671	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"smooth muscle: 127.8;urinary bladder: 105.1"	"Cell line enhanced"	"Detected in many"		"Daudi: 28.8;EFO-21: 35.8;U-698: 59.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 18.0"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA011133, HPA017342"	Enhanced		Enhanced	"Focal adhesion sites,Cytosol"		520000	520000	"Focal adhesion sites, Cytosol"	"Focal adhesion sites, Cytosol"	"HPA011133: AB_1853247, HPA017342: AB_1853249"	"unprognostic (1.50e-1)"	"unprognostic (4.97e-3)"	"unprognostic (1.41e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.86e-1)"	"unprognostic (4.05e-1)"	"unprognostic (2.43e-3)"	"unprognostic (7.97e-2)"	"unprognostic (2.17e-1)"	"unprognostic (5.56e-2)"	"unprognostic (3.44e-3)"	"unprognostic (2.10e-1)"	"unprognostic (2.57e-3)"	"unprognostic (2.25e-2)"	"unprognostic (6.86e-2)"	"unprognostic (2.82e-3)"	"unprognostic (1.48e-1)"	19.6	4.2	2.7	29.5	2.8	3.1	12.5	3.0	2.7	42.2	29.9	2.1	19.6	5.0	68.6	14.9	59.7	10.0	37.9	9.3	2.6	2.8	10.9	5.3	11.4	6.0	2.8	1.6	26.1	4.4	4.7	3.2	5.2	3.0	37.7	12.8	8.5	7.0	28.4	11.6	5.9	17.2	127.8	3.2	9.5	12.1	30.7	1.5	5.1	5.4	4.2	7.8	105.1	38.3	5.9	4.9	18.0	4.5	4.3	5.0	1.4	7.5	7.0	5.1	3.4	11.1	11.4	5.5	4.9	6.3	3.6	2.4	12.6	3.6	28.8	35.8	11.2	3.2	1.5	3.3	9.1	3.1	1.7	1.4	5.4	3.3	4.7	0.6	1.7	8.1	4.7	8.1	7.0	6.1	0.0	0.6	6.3	2.4	1.4	0.6	2.0	2.3	1.8	3.8	0.1	4.0	8.0	0.3	0.0	10.6	3.5	6.0	2.7	2.4	13.1	8.4	6.5	6.0	12.2	0.0	1.1	59.7	4.2	1.3	7.6	0.8	4.5	1.9	5.0	4.2	3.2	2.9	4.3	3.6	2.4	5.9	2.3	2.9	18.0	4.3	4.0	4.9	1.6	1.4	2.7	2.8	3.0	2.7	2.6	2.8	2.8	1.6	3.0	1.5
MMP12	HME	ENSG00000262406	"Matrix metallopeptidase 12"	P39900	11	102862736-102875034	"Cancer-related genes, Enzymes, FDA approved drug targets, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 42.4;urinary bladder: 13.2"	"Group enriched"	"Detected in some"	12	"BJ: 4.1;fHDF/TERT166: 14.3;hTEC/SVTERT24-B: 8.2"	"Low cancer specificity"	"Detected in all"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"								"Secreted to extracellular matrix"						"unprognostic (7.33e-2)"	"unprognostic (3.20e-2)"	"unprognostic (1.00e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.74e-1)"	"unprognostic (1.67e-1)"	"prognostic unfavourable (1.42e-4)"	"unprognostic (1.69e-2)"	"unprognostic (7.31e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.52e-3)"	"unprognostic (5.45e-2)"	"unprognostic (3.05e-6)"	"unprognostic (1.08e-2)"	"unprognostic (4.66e-2)"	"unprognostic (1.73e-1)"	"unprognostic (6.92e-2)"	2.7	0.0	0.0	21.2	0.0	0.0	0.0	0.0	0.0	0.3	6.9	0.0	0.0	3.3	0.0	5.9	0.0	0.0	1.0	0.0	0.0		0.0	0.4	0.6	18.9	0.0	0.0	0.1	0.0	0.0	0.0	9.7	0.0	0.3	8.4	0.0	0.9	0.0	0.0	0.0	3.8	4.6	0.0	42.4	1.3	0.1	0.0	5.5	0.0	1.5	9.9	13.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.4	0.2	0.0	0.1	0.0	0.0	0.0	14.3	0.5	0.0	0.0	0.4	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.5	0.6	0.2	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
MOB2	HCCA2	ENSG00000182208	"MOB kinase activator 2"	Q70IA6	11	1469457-1501247	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"smooth muscle: 57.3;urinary bladder: 51.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046313	Uncertain		Supported	Nucleoplasm,Nucleoli,Cytosol				Nucleoli	Nucleoli	"HPA046313: AB_10959882"	"unprognostic (5.02e-1)"	"unprognostic (5.71e-2)"	"unprognostic (6.24e-3)"	"unprognostic (4.42e-3)"	"prognostic unfavourable (4.64e-4)"	"unprognostic (8.30e-2)"	"unprognostic (1.06e-3)"	"unprognostic (3.06e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.80e-2)"	"unprognostic (5.30e-2)"	"unprognostic (2.87e-1)"	"prognostic favourable (2.02e-4)"	"unprognostic (2.67e-1)"	"unprognostic (8.56e-2)"	"unprognostic (9.78e-2)"	"unprognostic (1.15e-1)"	9.2	4.2	2.4	17.0	2.5	3.0	12.1	2.5	3.2	14.9	30.9	1.8	6.7	2.5	12.5	8.7	17.3	13.8	26.8	8.1	2.8	1.9	3.2	3.0	4.1	8.2	2.1	2.1	8.6	5.8	6.8	1.8	4.2	2.9	21.2	6.7	4.3	12.9	20.1	7.1	9.4	10.6	57.3	2.5	3.7	9.9	4.2	2.0	2.0	4.3	3.2	4.4	51.8	21.2	10.6	10.8	11.2	12.5	11.6	17.3	9.0	13.9	15.2	9.4	7.6	23.6	16.6	8.7	11.0	16.1	21.3	16.8	9.7	19.2	10.3	8.5	25.9	17.1	14.6	24.8	13.0	13.8	21.8	7.8	5.5	12.3	15.9	10.2	12.3	13.4	29.8	11.3	13.4	22.5	12.6	10.7	10.8	9.9	13.2	17.4	11.6	14.2	9.6	9.7	10.7	17.7	13.4	17.6	18.8	13.7	17.2	13.3	7.9	10.3	18.5	13.0	6.6	4.2	7.0	10.6	10.3	10.7	9.0	9.9	9.9	8.2	8.6	11.2	17.3	8.7	14.6	8.2	14.9	13.8	10.8	10.6	12.5	10.5	7.1	11.6	12.5	6.9	12.8	9.0	2.4	2.5	2.5	2.5	2.8	1.9	2.1	2.1	2.9	2.0
MSX2	"CRS2, FPP, HOX8, MSH, PFM, PFM1"	ENSG00000120149	"Msh homeobox 2"	P35548	5	174724533-174730893	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 44.7;urinary bladder: 18.2"	"Cell line enriched"	"Detected in some"	6	"BEWO: 83.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	7	"cerebellum: 6.9"	"Low region specificity"	"Detected in single"			HPA005652	Uncertain		Supported	"Nuclear speckles"				"Nuclear speckles"	"Nuclear speckles"	"HPA005652: AB_1079418"	"unprognostic (1.29e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.84e-1)"	"prognostic favourable (8.43e-5)"	"unprognostic (2.50e-2)"	"unprognostic (1.22e-2)"	"unprognostic (3.13e-1)"	"prognostic unfavourable (6.93e-4)"	"unprognostic (2.08e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.51e-2)"	"unprognostic (7.26e-2)"	"unprognostic (1.36e-4)"	"unprognostic (7.64e-3)"	"unprognostic (5.06e-2)"	"unprognostic (2.12e-6)"	"unprognostic (1.43e-2)"	2.0	0.4	0.3	0.4	0.5	0.0	7.6	6.3	1.6	2.6	0.9	2.0	0.0	0.3	6.2	0.2	0.9	1.1	1.5	1.7	2.5	0.5	0.3	0.1	0.9	0.1	1.5	1.2	0.4	0.6	9.4	0.5	44.7	7.2	6.3	0.1	6.6	0.9	0.8	2.1	6.4	0.9	10.4	6.6	1.1	2.6	5.2	1.3	0.0	0.8	0.2	0.3	18.2	2.4	0.0	0.0	0.0	0.0	0.2	0.5	0.1	0.1	1.0	0.2	0.8	0.0	0.0	83.8	0.5	0.9	0.2	0.0	14.2	5.8	0.0	2.2	0.0	1.5	4.5	1.6	0.0	0.0	2.7	0.0	0.3	0.0	0.6	0.0	0.7	0.9	1.1	0.8	0.9	0.0	0.0	0.0	1.2	6.9	0.0	0.1	0.6	2.2	0.0	2.2	0.0	1.0	8.9	0.0	0.6	0.0	11.0	0.7	6.6	0.0	0.0	0.2	1.4	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.1	0.0	0.0	0.1	0.3	0.0	0.2	0.0	0.0	0.0	0.1	0.3	0.5	6.3	1.6	2.5	0.5	1.5	1.2	7.2	1.3
MYH11	"SMHC, SMMHC"	ENSG00000133392	"Myosin heavy chain 11"	P35749	16	15703172-15857033	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 507.4;urinary bladder: 394.5"	"Cell line enhanced"	"Detected in some"		"BEWO: 3.5;NB-4: 3.8;U-698: 9.7"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 173.2"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"midbrain: 54.5"	"CAB002302, HPA014539, HPA015310"	Enhanced		Supported	"Plasma membrane,Cytosol"		130000000	130000000	"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"CAB002302: AB_563902, HPA014539: AB_1234906, HPA015310: AB_1854261"	"unprognostic (7.99e-2)"	"unprognostic (3.07e-2)"	"unprognostic (4.18e-2)"	"unprognostic (9.21e-3)"	"unprognostic (6.70e-2)"	"unprognostic (2.75e-2)"	"prognostic favourable (1.10e-5)"	"unprognostic (1.41e-2)"	"unprognostic (1.87e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.19e-3)"	"unprognostic (4.06e-2)"	"unprognostic (9.53e-2)"	"unprognostic (5.00e-2)"	"unprognostic (5.45e-3)"	13.2	3.0	0.6	31.5	1.2	0.0	5.9	0.5	1.7	90.3	227.5	1.3	100.0	11.6	102.0	38.4	233.0	43.8	94.3	6.2	0.6	0.7	4.7	0.7	8.5	1.5	1.4	2.6	45.5	1.3	0.0	1.0	5.3	3.6	164.7	22.2	37.0	8.8	127.2	6.4	5.0	50.6	507.4	1.4	3.7	77.7	22.3	0.2	0.1	3.7	6.2	3.0	394.5	57.5	1.5	0.9	6.0	0.9	1.1	1.5	0.4	0.1	0.4	0.2	0.1	0.0	0.0	3.5	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.2	0.0	0.6	0.0	0.0	0.0	0.4	0.4	0.2	0.1	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.1	1.5	0.0	0.3	0.3	3.8	0.4	0.1	0.4	0.1	1.9	0.0	0.2	0.7	1.4	0.2	0.5	1.2	0.4	0.0	0.3	0.1	0.3	2.0	0.1	0.4	0.4	9.7	0.4	0.4	0.4	3.1	0.9	2.7	1.2	0.6	1.2	1.5	1.5	1.4	0.5	1.2	1.4	1.4	6.0	1.1	0.6	0.9	1.4	0.4	0.6	1.2	0.5	1.7	0.6	0.7	1.4	2.6	3.6	0.2
MYL9	"LC20, MLC2, MRLC1, MYRL2"	ENSG00000101335	"Myosin light chain 9"	P24844	20	36541484-36551447	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 717.2;urinary bladder: 496.7"	"Cell line enhanced"	"Detected in many"		"ASC diff: 85.0;BJ: 110.2;fHDF/TERT166: 87.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"eosinophil: 2.6;neutrophil: 2.7"	"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in many"			"HPA039262, HPA045244, HPA059197"	Supported		Approved	"Nucleoplasm,Nucleoli fibrillar center"		92000000	92000000	"Nucleoplasm, Nucleoli fibrillar center"	"Nucleoplasm, Nucleoli fibrillar center"	"HPA039262: AB_2676418, HPA045244: AB_2679269, HPA059197: AB_2683944"	"unprognostic (1.15e-1)"	"unprognostic (5.05e-2)"	"unprognostic (2.67e-3)"	"unprognostic (5.38e-2)"	"unprognostic (7.17e-2)"	"unprognostic (5.06e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.59e-1)"	"unprognostic (9.06e-2)"	"unprognostic (8.90e-2)"	"prognostic unfavourable (7.92e-7)"	"unprognostic (1.90e-2)"	"unprognostic (8.41e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.92e-2)"	61.9	46.0	2.0	58.1	5.8	0.2	64.8	1.4	6.4	123.3	361.6	6.0	162.9	22.7	278.8	102.0	242.7	80.3	199.0	169.8	1.9	2.1	27.7	6.8	36.0	14.9	4.7	8.7	107.8	5.4	2.8	4.8	31.7	10.5	218.9	30.4	71.8	22.6	203.9	22.2	14.7	70.3	717.2	5.2	22.8	120.7	55.1	1.4	1.4	48.8	21.9	8.7	496.7	107.7	1.2	0.5	2.7	0.2	0.3	0.1	10.8	8.0	0.1	6.4	0.1	85.0	32.7	28.3	110.2	47.7	57.7	37.5	63.5	0.9	0.0	57.8	87.5	3.0	0.0	0.2	13.6	0.0	0.0	1.6	12.4	5.9	54.9	0.0	1.9	45.7	5.8	38.1	0.1	2.0	0.2	2.9	48.4	0.0	0.0	0.8	2.5	0.5	0.0	0.0	0.5	0.4	0.6	0.0	0.4	1.1	2.8	0.0	24.6	1.6	14.1	55.2	23.3	8.0	0.1	0.0	0.4	0.2	20.9	0.0	0.0	0.0	0.2	2.6	0.0	0.0	0.1	1.2	0.0	0.1	0.3	0.2	0.0	0.0	2.7	0.3	0.0	0.5	0.0	10.8	2.0	5.8	1.4	6.4	1.9	2.1	4.7	8.7	10.5	1.4
OR10H1		ENSG00000186723	"Olfactory receptor family 10 subfamily H member 1"	Q9Y4A9	19	15804549-15815664	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"blood: 3.7;urinary bladder: 6.1"	"Cell line enhanced"	"Detected in many"		"RT4: 7.8"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"																							"unprognostic (3.29e-1)"				"unprognostic (1.97e-3)"				"unprognostic (4.18e-1)"	"unprognostic (1.63e-2)"	"unprognostic (2.38e-1)"					"unprognostic (9.30e-2)"	0.4	0.3	0.3	0.4	0.3	2.3	0.5	0.3	0.8	0.3	0.3			1.1	0.3	1.3	0.4	0.3	0.2	0.3	0.3	0.3	0.3	0.3	0.3	0.4	0.3		0.6	0.3	0.2	0.4	0.0		0.9	0.2		0.4	0.0	2.1	1.8	0.6	0.2	0.3	0.3	0.3	1.8			0.3		0.1	6.1	0.4	1.1	1.0	3.7	0.7	1.2	0.7	0.1	1.1	0.5	1.1	0.8	0.1	0.5	1.1	1.6	0.0	0.1	0.2	0.5	2.0	1.2	1.3	0.4	1.0	0.4	0.6	0.3	0.9	0.6	1.7	1.5	0.6	0.2	1.0	2.1	0.4	0.2	0.4	0.3	0.0	0.7	2.6	0.3	0.3	0.7	1.0	1.2	0.5	0.9	0.9	0.7	0.6	7.8	0.7	0.6	2.9	0.8	0.8	0.5	0.5	1.6	2.4	2.1	1.1	1.6	1.4	0.9	1.1	0.9	0.7	0.7	3.7	0.7	0.6	0.5	0.4	0.6	0.6	0.5	0.4	0.2	1.1	0.6	0.7	3.7	1.2	0.4	1.0	0.4	0.1										
OR13A1		ENSG00000256574	"Olfactory receptor family 13 subfamily A member 1"	Q8NGR1	10	45302298-45315608	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 2.3;urinary bladder: 4.2"	"Group enriched"	"Detected in some"	34	"Daudi: 13.2;U-698: 12.2"	"Cancer enhanced"	"Detected in single"		"urothelial cancer: 0.8"					"Cell type enhanced"	"Detected in single"		"memory B-cell: 2.0"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"							HPA057237	Uncertain									"HPA057237: AB_2683378"	"unprognostic (7.88e-2)"	"unprognostic (1.90e-1)"	"unprognostic (5.52e-2)"	"unprognostic (2.33e-5)"	"unprognostic (6.43e-3)"	"unprognostic (6.04e-2)"		"unprognostic (8.65e-2)"	"unprognostic (3.59e-1)"	"unprognostic (2.45e-1)"	"unprognostic (2.54e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.67e-15)"	"unprognostic (6.54e-2)"	"unprognostic (2.87e-1)"	"unprognostic (8.55e-2)"	"unprognostic (4.09e-3)"	0.0	0.0	0.1	0.4	0.2	0.5	0.1	1.9	0.1	0.0	0.2			0.0	0.0	0.0	1.4	0.1	0.0	0.0	0.2	0.3	0.0	0.0	0.4	2.2	0.2		0.1	0.2	0.0	0.0	0.0		0.9	0.3		0.5	0.0	0.3	0.0	1.6	0.0	0.4	2.3	0.2	0.3			0.0		2.0	4.2	0.3	2.0	0.0	0.0	0.9	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	12.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	2.0	0.2	0.0	0.0	0.1	0.3	0.9	0.0	0.0	0.9	0.0	0.0	0.0										
OR1G1	"OR17-209, OR1G2"	ENSG00000183024	"Olfactory receptor family 1 subfamily G member 1"	P47890	17	3126584-3127581	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"testis: 1.6;urinary bladder: 1.0"	"Cell line enhanced"	"Detected in single"		"HBEC3-KT: 1.3"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"																															0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.1	0.0			0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2		0.0	0.0	0.0	0.0	0.0		0.2	0.0		0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.6			0.5		0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0										
OR1J2	"OR1J3, OR1J5, OST044"	ENSG00000197233	"Olfactory receptor family 1 subfamily J member 2"	Q8NGS2	9	122510802-122511743	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"epididymis: 1.3;testis: 1.2;urinary bladder: 1.7"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 3.3;HSkMC: 1.3"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.1			0.0	0.4	1.3	0.0	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.2	0.3	0.0		0.0	0.1	0.0	0.0	0.0		0.0	0.0		0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.2	1.2			0.0		0.0	1.7	0.0	0.5	0.6	0.6	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.3	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.5	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.6	0.0	0.0	0.5	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0										
OR1L1	"OR1L2, OR9-C"	ENSG00000173679	"Olfactory receptor family 1 subfamily L member 1"	Q8NH94	9	122661566-122662648	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in single"		"urinary bladder: 1.5"	"Cell line enriched"	"Detected in single"	20	"RT4: 2.0"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.5	0.0			0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.1	0.0		0.0	0.0		0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4			0.0		0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
OR4F17	"OR4F11P, OR4F18, OR4F19"	ENSG00000176695	"Olfactory receptor family 4 subfamily F member 17"	Q8NGA8	19	107104-117102	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in single"		"urinary bladder: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.9	0.2			0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.1		0.0	0.2	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.6			0.0		0.0	1.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.3	0.2	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0										
OR5B21		ENSG00000198283	"Olfactory receptor family 5 subfamily B member 21"	A6NL26	11	58507175-58508105	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"testis: 1.9;urinary bladder: 1.1"	"Cell line enhanced"	"Detected in some"		"HMC-1: 3.4;hTEC/SVTERT24-B: 1.6;U-2197: 1.1"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																															0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0		0.0	0.0	0.0	0.0	0.1		0.0	0.0		0.1	0.0	0.5	0.0	0.2	0.0	0.0	0.3	0.2	1.9			0.0		0.8	1.1	0.0	0.7	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	1.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
OR5M11	OR11-199	ENSG00000255223	"Olfactory receptor family 5 subfamily M member 11"	Q96RB7	11	56542262-56543281	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"testis: 1.3;urinary bladder: 1.8"	"Cell line enhanced"	"Detected in single"		"RT4: 2.6"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																																						"unprognostic (2.95e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.1	0.0		0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.3			0.0		0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.7	0.0	2.6	0.0	0.0	0.0	0.4	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
OR5P3	JCG1	ENSG00000182334	"Olfactory receptor family 5 subfamily P member 3"	Q8WZ94	11	7824818-7830840	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"epididymis: 1.7;skin 1: 2.1;urinary bladder: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA060787	Uncertain									"HPA060787: AB_2684364"																	"unprognostic (1.54e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0			0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.2	0.0		0.1	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.1	0.5			0.0		0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
OSR1	ODD	ENSG00000143867	"Odd-skipped related transciption factor 1"	Q8TAX0	2	19351485-19358653	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 68.3;urinary bladder: 62.1"	"Cell line enriched"	"Detected in some"	11	"U-2197: 47.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA015525	Uncertain									"HPA015525: AB_1854822"	"unprognostic (1.71e-3)"	"unprognostic (1.23e-1)"	"unprognostic (6.85e-4)"	"unprognostic (1.42e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.45e-2)"	"unprognostic (8.47e-4)"	"unprognostic (2.79e-1)"	"unprognostic (1.91e-1)"	"unprognostic (6.87e-2)"	"unprognostic (3.56e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.21e-3)"	"unprognostic (1.89e-1)"	"unprognostic (1.74e-1)"	"unprognostic (2.51e-2)"	"unprognostic (1.62e-1)"	16.9	1.3	0.2	5.0	0.5	0.1	40.0	0.7	1.0	12.6	11.7	0.3	2.0	1.3	9.2	5.6	18.5	4.0	5.7	21.3	0.6	0.2	0.9	0.3	7.9	2.6	0.2	0.8	5.2	2.6	0.2	1.2	3.7	1.5	45.5	1.9	1.6	28.4	3.6	5.9	5.1	5.2	68.3	0.5	0.1	5.1	5.7	0.0	0.1	6.0	7.2	5.0	62.1	13.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	2.1	1.5	4.4	0.0	2.7	1.2	2.6	1.3	0.0	0.0	0.0	0.0	3.8	0.0	1.3	0.6	0.6	0.0	0.1	0.0	0.0	1.5	1.9	0.0	0.0	2.1	0.0	2.4	3.1	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	2.3	0.0	0.1	0.0	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.2	47.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.7	1.0	0.6	0.2	0.2	0.8	1.5	0.0
P2RX1	P2X1	ENSG00000108405	"Purinergic receptor P2X 1"	P51575	17	3896592-3916500	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 98.3;urinary bladder: 60.0"	"Cell line enhanced"	"Detected in some"		"HEL: 12.1;HMC-1: 7.8;Karpas-707: 15.2;THP-1: 12.5;U-937: 6.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 22.4"	"Group enriched"	"Detected in many"	22	"dendritic cells: 8.2;granulocytes: 12.8;monocytes: 22.4"	"Low region specificity"	"Detected in some"			"Region enriched"	"Detected in single"	6	"midbrain: 2.0"							1300000	1300000				"unprognostic (1.27e-3)"	"unprognostic (1.61e-2)"	"unprognostic (2.65e-1)"	"unprognostic (3.54e-2)"	"unprognostic (7.34e-3)"	"unprognostic (9.89e-5)"	"unprognostic (1.77e-2)"	"unprognostic (6.15e-3)"	"unprognostic (2.98e-1)"	"unprognostic (2.52e-3)"	"unprognostic (1.90e-1)"	"unprognostic (2.20e-2)"	"unprognostic (4.47e-3)"	"unprognostic (2.60e-1)"	"unprognostic (5.58e-2)"	"unprognostic (4.29e-1)"	"unprognostic (1.09e-2)"	5.2	0.7	0.3	2.9	0.5	17.0	1.1	0.3	0.6	5.9	6.3	0.5	10.7	4.0	4.2	5.2	11.0	2.0	3.0	1.1	0.4	0.3	0.9	0.6	3.8	2.0	0.4	0.5	2.4	29.7	0.0	0.4	1.8	0.5	15.3	4.1	0.7	1.8	16.9	1.0	3.0	4.6	98.3	0.7	6.7	1.4	1.6	0.5	1.5	0.5	1.2	2.7	60.0	5.8	0.6	8.2	12.8	22.4	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.1	0.1	0.1	1.0	1.6	7.8	0.0	0.0	0.0	0.0	0.0	0.0	15.2	0.0	0.0	0.2	3.0	0.0	0.0	2.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.5	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.2	0.1	6.5	0.0	0.0	5.8	6.1	0.0	10.6	0.0	0.2	0.0	0.0	3.2	0.6	0.0	0.0	12.8	0.0	22.4	8.2	0.0	4.5	0.3	0.5	0.3	0.6	0.4	0.3	0.4	0.5	0.5	0.5
PADI3	PDI3	ENSG00000142619	"Peptidyl arginine deiminase 3"	Q9ULW8	1	17249098-17284233	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 10.5;smooth muscle: 9.4;urinary bladder: 28.0"	"Cell line enhanced"	"Detected in some"		"EFO-21: 13.2;RT4: 15.8;T-47d: 11.9"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 48.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA043739	Uncertain		Approved	Nucleoplasm,Vesicles				Vesicles	Vesicles	"HPA043739: AB_10959466"	"unprognostic (4.47e-2)"	"unprognostic (9.32e-2)"	"unprognostic (1.50e-1)"	"prognostic unfavourable (3.22e-4)"	"unprognostic (1.05e-3)"	"unprognostic (6.66e-2)"	"unprognostic (3.10e-3)"	"unprognostic (5.88e-2)"	"unprognostic (2.06e-4)"	"unprognostic (1.03e-1)"	"unprognostic (3.47e-4)"	"unprognostic (1.76e-1)"	"prognostic unfavourable (1.55e-11)"	"unprognostic (2.40e-2)"	"unprognostic (4.73e-3)"		"unprognostic (2.64e-2)"	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	5.1	0.0	0.0	3.2	10.5	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.4	0.0	0.0	0.6	6.4	0.0	2.3	0.0	9.4	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.7	28.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	13.2	0.0	0.2	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	15.8	0.0	0.0	0.0	2.3	0.1	11.9	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PCP4L1	IQM1	ENSG00000248485	"Purkinje cell protein 4 like 1"	A6NKN8	1	161258727-161285450	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 67.7;urinary bladder: 33.2"	"Group enriched"	"Detected in some"	6	"RT4: 15.7;T-47d: 10.3"	"Group enriched"	"Detected in many"	6	"cervical cancer: 12.4;head and neck cancer: 5.1;lung cancer: 13.6;testis cancer: 18.9;urothelial cancer: 21.8"	"Group enriched"	"Detected in all"	5	"basal ganglia: 67.7;cerebral cortex: 17.9;pons and medulla: 30.8"	"Cell type enhanced"	"Detected in single"		"T-reg: 3.1"	"Lineage enhanced"	"Detected in single"		"T-cells: 3.1"	"Low region specificity"	"Detected in all"							HPA052833	Enhanced	Supported	Approved	Nucleoplasm,Mitochondria				"Nucleoplasm, Mitochondria"	"Nucleoplasm, Mitochondria"	"HPA052833: AB_2681968"	"unprognostic (1.81e-2)"	"unprognostic (9.39e-2)"	"unprognostic (5.25e-2)"	"unprognostic (2.07e-1)"	"unprognostic (3.03e-2)"	"unprognostic (1.87e-2)"	"unprognostic (2.51e-1)"	"prognostic favourable (8.10e-5)"	"unprognostic (2.39e-1)"	"unprognostic (1.92e-1)"	"unprognostic (4.93e-2)"	"unprognostic (7.37e-2)"	"unprognostic (3.63e-5)"	"unprognostic (4.81e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.09e-1)"	"unprognostic (6.15e-2)"	3.2	1.0	5.7	1.3	67.7	0.6	2.2	4.4	28.9	4.3	4.3	1.4	1.5	2.2	2.2	3.3	16.5	2.1	3.9	1.3	3.9	6.3	1.0	4.3	5.0	0.7	7.8	4.6	2.6	0.5	0.6	21.9	0.9	30.8	5.5	3.2	5.9	1.2	17.8	1.0	2.8	3.3	6.8	7.5	0.8	1.2	2.3	5.3	0.0	1.0	0.0	3.0	33.2	4.1	0.0	0.7	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	1.9	0.0	0.0	0.0	0.0	0.0	2.1	0.4	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.3	0.0	0.1	0.0	0.1	0.0	15.7	2.2	0.0	0.0	0.3	0.0	10.3	0.4	0.2	0.0	0.0	0.0	0.0	0.9	1.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	5.7	67.7	4.4	17.9	3.9	6.3	7.8	4.6	30.8	5.3
PLA2G2F		ENSG00000158786	"Phospholipase A2 group IIF"	Q9BZM2	1	20139326-20150386	"Enzymes, Predicted membrane proteins, RAS pathway related proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 11.1;skin 1: 13.7;urinary bladder: 19.5"	"Cell line enriched"	"Detected in single"	67	"RT4: 54.8"	"Cancer enriched"	"Detected in some"	18	"urothelial cancer: 17.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	4	"hippocampal formation: 3.3"	"Not detected"	"Not detected"								"Intracellular and membrane"						"unprognostic (1.95e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.79e-2)"		"unprognostic (5.11e-2)"		"unprognostic (4.63e-2)"	"unprognostic (4.83e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.61e-2)"	"unprognostic (3.36e-5)"		"unprognostic (7.06e-2)"	"unprognostic (1.84e-1)"	"unprognostic (4.69e-1)"	"prognostic favourable (3.86e-4)"	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	4.8	0.0	7.7	0.0	0.0	0.0	0.0	0.0	13.7	0.1	6.5	0.0	0.0	0.3	0.1	0.0	2.8	0.0	6.3	11.1	19.5	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	54.8	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0
PRDM6	"KMT8C, PRISM"	ENSG00000061455	"PR/SET domain 6"	Q9NQX0	5	123089121-123194266	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 19.7;smooth muscle: 29.7;urinary bladder: 18.4;vagina: 18.7"	"Cell line enhanced"	"Detected in some"		"BEWO: 6.8;HEK 293: 9.6"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in single"	6	"pons and medulla: 3.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA030324	Uncertain		Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA030324: AB_10670032"	"unprognostic (2.33e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.32e-3)"	"unprognostic (3.12e-1)"	"unprognostic (5.44e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.54e-2)"	"unprognostic (4.66e-2)"	"unprognostic (7.66e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.02e-7)"	"unprognostic (9.30e-4)"	"unprognostic (1.10e-1)"	"unprognostic (3.43e-4)"	"unprognostic (1.27e-1)"	1.3	0.3	0.3	0.6	0.3	0.0	1.4	0.4	0.5	1.6	6.7	0.4	0.3	0.4	1.8	0.6	1.2	0.6	19.7	0.9	0.4	0.3	0.6	0.3	10.6	0.0	0.5	0.4	3.8	0.5	0.3	0.5	8.1	3.6	14.1	1.9	0.0	0.3	0.8	0.2	0.4	1.0	29.7	0.8	0.1	1.1	0.5	0.0	0.0	1.4	0.2	0.6	18.4	18.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.6	0.9	6.8	0.1	0.0	0.0	0.1	0.1	0.3	0.1	0.2	0.5	0.0	1.4	0.0	0.0	0.3	9.6	2.0	0.9	0.0	2.0	0.0	0.3	0.1	0.1	0.2	0.1	0.0	0.0	0.2	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.2	1.1	0.4	0.1	1.5	0.0	0.0	0.6	0.0	0.1	0.2	0.0	0.0	0.4	0.1	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.4	0.5	0.4	0.3	0.5	0.4	3.6	0.0
PSCA		ENSG00000167653	"Prostate stem cell antigen"	O43653	8	142670308-142682724	"Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 72.6;stomach 1: 230.2;urinary bladder: 112.0"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 11.5;HeLa: 22.2;RT4: 31.8;SK-BR-3: 8.1"	"Cancer enriched"	"Detected in many"	6	"urothelial cancer: 785.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA030783, HPA056418"	Approved		Supported	"Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"HPA030783: AB_2673611, HPA056418: AB_2683123"	"unprognostic (1.21e-3)"	"unprognostic (1.76e-3)"	"unprognostic (3.20e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.77e-2)"	"unprognostic (7.57e-2)"	"unprognostic (1.93e-2)"	"unprognostic (7.81e-3)"	"unprognostic (8.25e-3)"	"unprognostic (2.13e-1)"	"prognostic unfavourable (5.60e-5)"	"unprognostic (6.82e-2)"	"unprognostic (2.38e-3)"	"unprognostic (4.93e-2)"	"unprognostic (2.68e-1)"	"unprognostic (3.07e-1)"	"unprognostic (1.06e-3)"	0.4	0.2	0.0	0.2	0.0	0.2	0.3	0.0	0.2	7.0	2.4	0.7	0.1	0.6	0.3	0.2	72.6	1.1	21.2	0.1	0.0	0.0	2.6	0.1	3.0	0.2	0.0	0.0	0.1	0.3	0.1	0.5	17.2	0.0	30.1	0.7	0.1	11.7	0.6	0.1	0.8	1.5	18.9	0.0	0.2	230.2	0.2	0.0	0.0	0.1	9.3	35.1	112.0	54.5	0.0	0.8	0.0	0.3	0.0	0.0	0.0	5.3	0.3	0.0	0.0	1.1	3.7	5.5	2.5	0.5	1.1	0.9	0.0	11.5	0.0	0.2	0.2	1.1	0.0	0.2	0.6	0.3	0.0	0.0	22.2	0.0	0.0	0.0	0.7	3.2	4.1	2.4	0.0	0.0	0.0	0.0	0.8	2.9	0.8	0.3	0.6	0.6	0.3	0.0	0.4	0.5	31.8	0.1	0.2	2.6	8.1	1.7	0.1	0.1	0.5	0.8	0.9	1.5	0.0	1.0	0.0	0.0	1.5	0.4	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0
PTGS1	"COX1, PGHS-1, PTGHS"	ENSG00000095303	"Prostaglandin-endoperoxide synthase 1"	P23219	9	122370530-122395703	"Cancer-related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 211.4;urinary bladder: 163.9"	"Cell line enhanced"	"Detected in some"		"ASC diff: 28.1;ASC TERT1: 22.3;BJ: 27.3;BJ hTERT+: 37.3;HEL: 17.1;HMC-1: 72.7"	"Cancer enhanced"	"Detected in all"		"ovarian cancer: 53.4"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"dendritic cells: 13.0;granulocytes: 14.4;monocytes: 8.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002834, CAB020315"	Enhanced		Supported	"Golgi apparatus,Vesicles"	"Intracellular and membrane"	25000000	25000000	"Golgi apparatus"	"Golgi apparatus"	"CAB020315: , HPA002834: AB_1079711"	"unprognostic (4.20e-1)"	"unprognostic (6.23e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.27e-2)"	"unprognostic (5.88e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.22e-3)"	"unprognostic (3.32e-1)"	"unprognostic (2.24e-1)"	"unprognostic (3.16e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.46e-1)"	"prognostic unfavourable (8.68e-4)"	"unprognostic (4.03e-2)"	"unprognostic (1.78e-2)"	"unprognostic (2.08e-1)"	"prognostic unfavourable (9.35e-4)"	4.5	1.1	1.8	9.1	3.1	2.6	2.5	0.5	2.7	2.6	35.3	4.6	3.0	3.9	2.5	1.6	25.7	16.7	9.4	4.9	1.9	1.6	3.9	1.8	4.0	1.4	3.5	0.7	3.6	1.0	0.7	2.4	0.8	2.5	60.9	9.3	1.5	1.9	2.3	0.7	55.9	6.5	211.4	4.9	3.6	7.8	1.0	3.1	0.4	1.5	5.3	4.2	163.9	19.5	2.5	13.0	14.4	8.5	1.9	0.1	13.7	0.0	0.1	0.1	0.0	28.1	22.3	0.0	27.3	37.3	0.2	0.2	0.0	0.0	0.9	1.3	4.6	1.7	0.0	2.5	0.2	0.0	0.0	17.1	0.1	0.0	8.1	1.1	72.7	11.4	0.2	1.4	0.0	10.1	0.0	0.0	0.5	0.0	0.0	1.5	0.3	0.1	0.0	0.3	2.0	3.5	0.0	0.1	0.1	0.1	2.3	0.0	0.0	1.9	0.2	0.1	0.1	0.4	0.0	0.0	0.0	0.0	0.1	7.4	0.0	12.0	7.6	14.4	0.0	8.5	0.0	1.7	0.0	0.0	13.0	2.5	0.0	0.0	3.5	1.9	6.1	0.9	0.1	13.7	1.8	3.1	0.5	2.7	1.9	1.6	3.5	0.7	2.5	3.1
PTPRQ	DFNB84	ENSG00000139304	"Protein tyrosine phosphatase, receptor type Q"		12	80402178-80680271	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"brain: 12.6;urinary bladder: 19.2"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 8.2;BJ: 6.1;HBF TERT88: 4.3;RH-30: 4.8;RT4: 5.3;U-2197: 5.1"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	24	"basal ganglia: 12.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA053245	Uncertain		Approved	Cytosol				Cytosol	Cytosol	"HPA053245: AB_2682087"	"unprognostic (9.10e-2)"	"unprognostic (1.63e-1)"		"unprognostic (1.15e-1)"	"unprognostic (3.30e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.93e-2)"	"unprognostic (1.04e-2)"		"unprognostic (1.46e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.78e-1)"	"unprognostic (4.47e-11)"	"unprognostic (8.51e-3)"	"unprognostic (1.47e-1)"	"unprognostic (1.73e-2)"	"unprognostic (2.66e-2)"	4.6	0.2	0.3	1.0	12.6	0.0	5.2	0.2	0.3	1.7	1.3	0.0	1.6	0.0	0.5	4.7	1.6	4.1	0.5	1.3	0.4	0.5	6.5	0.2	5.4	2.1	0.2	0.0	0.9	0.6	0.0	1.1	6.4	0.0	6.5	0.0	0.0	0.4	0.5	0.5	0.3	0.2	4.0	0.2	0.2	0.2	5.8	0.0	0.0	3.9	0.0	0.6	19.2	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	8.2	0.0	6.1	1.3	1.9	1.3	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.9	0.0	0.3	0.0	0.0	0.9	0.0	0.8	0.2	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	5.3	0.0	0.0	3.0	0.1	0.0	0.3	0.0	0.0	0.5	0.1	5.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	12.6	0.2	0.3	0.4	0.5	0.2	0.0	0.0	0.0
PTX3	"TNFAIP5, TSG-14"	ENSG00000163661	"Pentraxin 3"	P26022	3	157436789-157443628	"Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 61.7;skeletal muscle: 67.7;urinary bladder: 77.0"	"Cell line enhanced"	"Detected in many"		"ASC diff: 84.6;ASC TERT1: 122.6;BJ hTERT+: 80.5;HHSteC: 157.4;HSkMC: 163.9;hTEC/SVTERT24-B: 86.6;TIME: 116.7;U-2197: 108.8"	"Cancer enhanced"	"Detected in many"		"glioma: 22.5"	"Group enriched"	"Detected in some"	6	"hippocampal formation: 1.1;pons and medulla: 3.6"	"Cell type enhanced"	"Detected in some"		"eosinophil: 3.2"	"Group enriched"	"Detected in many"	20	"dendritic cells: 1.3;granulocytes: 3.2;monocytes: 1.2"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA069320	Approved		Approved	"Plasma membrane"	"Secreted to blood"	310000	310000	"Plasma membrane"	"Plasma membrane"	"HPA069320: AB_2686118"	"unprognostic (1.93e-2)"	"unprognostic (4.96e-3)"	"unprognostic (1.35e-1)"	"prognostic unfavourable (8.35e-9)"	"unprognostic (5.79e-3)"	"prognostic unfavourable (6.36e-4)"	"unprognostic (6.03e-3)"	"prognostic unfavourable (8.75e-6)"	"unprognostic (2.45e-1)"	"unprognostic (6.69e-2)"	"unprognostic (7.60e-2)"	"unprognostic (2.63e-1)"	"unprognostic (2.76e-9)"	"unprognostic (6.03e-3)"	"unprognostic (5.98e-2)"	"unprognostic (2.15e-4)"	"unprognostic (1.92e-3)"	61.7	3.4	0.3	16.7	0.2	31.6	35.3	0.2	0.7	0.8	13.2	0.3	0.6	0.5	0.5	0.8	2.0	6.5	3.5	14.7	1.1	0.0	3.0	0.6	22.5	7.0	0.3	0.1	6.8	18.0	0.3	1.0	4.9	3.6	2.5	1.2	5.2	1.8	0.4	67.7	6.0	1.9	6.4	0.9	9.6	4.9	0.9	0.2	0.3	2.7	0.4	0.4	77.0	2.5	0.0	1.3	3.2	1.2	0.0	0.0	0.1	0.0	0.0	51.0	0.0	84.6	122.6	0.0	8.8	80.5	3.8	4.1	0.0	0.5	0.0	31.4	10.3	0.0	0.0	0.0	7.5	0.0	0.0	0.1	0.0	0.0	157.4	0.1	0.0	163.9	0.0	86.6	29.5	17.8	0.0	0.0	25.4	0.0	0.0	0.1	0.7	0.3	0.0	0.0	0.0	0.3	3.5	0.4	0.0	0.5	0.0	0.0	0.0	0.1	116.7	17.3	0.8	108.8	1.5	0.0	0.0	0.0	3.6	0.4	4.9	0.0	1.2	3.2	0.0	1.2	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.1	0.3	0.2	0.2	0.2	1.1	0.0	0.3	0.1	3.6	0.2
RAB23		ENSG00000112210	"RAB23, member RAS oncogene family"	Q9ULC3	6	57186992-57222314	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 62.4;urinary bladder: 48.9"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 32.0;U-2197: 56.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029135, HPA029136"	Enhanced		Enhanced	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"HPA029135: AB_10602070, HPA029136: AB_10601794"	"unprognostic (8.78e-2)"	"unprognostic (6.55e-2)"	"unprognostic (7.17e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.14e-2)"	"unprognostic (2.28e-2)"	"unprognostic (2.55e-2)"	"unprognostic (5.33e-3)"	"unprognostic (6.41e-2)"	"unprognostic (6.55e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.97e-2)"	"unprognostic (9.12e-3)"	"unprognostic (1.36e-2)"	"unprognostic (2.38e-1)"	"unprognostic (6.37e-2)"	"unprognostic (1.46e-3)"	6.0	3.0	6.7	5.7	5.1	0.2	4.0	7.3	4.8	23.1	32.9	5.1	9.6	3.0	34.1	8.0	9.7	8.1	12.4	7.0	7.4	4.5	3.3	1.8	4.9	1.7	6.4	5.4	8.2	1.6	2.9	3.5	12.3	6.7	24.9	7.5	3.6	2.8	26.9	4.7	3.1	7.0	62.4	6.6	1.1	8.7	4.3	7.2	1.4	15.1	3.9	1.7	48.9	11.2	0.3	1.5	1.3	0.6	0.9	2.0	0.3	4.7	1.9	6.8	4.8	10.5	32.0	6.3	14.0	24.3	12.3	12.8	4.1	2.3	0.9	4.4	22.4	1.7	7.1	5.1	14.7	3.5	3.3	3.4	3.1	3.2	6.5	1.8	0.5	11.9	5.9	15.3	14.4	6.4	5.2	2.9	13.6	4.0	1.5	1.9	2.5	2.6	1.7	10.1	1.4	8.5	3.3	3.5	2.4	7.0	3.3	3.6	3.0	2.0	8.5	19.2	6.0	56.4	8.1	2.5	2.8	2.3	10.8	3.8	9.4	0.3	0.4	1.3	0.3	0.4	0.0	0.3	1.1	0.5	0.3	0.3	2.0	0.8	0.0	0.9	0.6	1.5	0.0	0.3	6.7	5.1	7.3	4.8	7.4	4.5	6.4	5.4	6.7	7.2
RBPMS2		ENSG00000166831	"RNA binding protein, mRNA processing factor 2"	Q6ZRY4	15	64739892-64775587	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 75.1;smooth muscle: 69.6;urinary bladder: 51.6"	"Cell line enhanced"	"Detected in many"		"AF22: 16.1;AN3-CA: 22.7;HAP1: 11.7;HEL: 34.2;NTERA-2: 31.4;U-2 OS: 12.1"	"Cancer enhanced"	"Detected in all"		"testis cancer: 37.2"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 1.6;naive B-cell: 3.0"	"Lineage enhanced"	"Detected in single"		"B-cells: 3.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"														"unprognostic (1.68e-1)"	"unprognostic (2.29e-1)"	"unprognostic (1.07e-2)"	"unprognostic (6.79e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.61e-1)"	"unprognostic (4.51e-2)"	"unprognostic (6.41e-2)"	"unprognostic (5.86e-2)"	"unprognostic (2.21e-2)"	"unprognostic (4.47e-2)"	"prognostic favourable (1.48e-4)"	"unprognostic (2.05e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.23e-1)"	"unprognostic (4.68e-3)"	6.9	1.1	0.7	5.8	0.9	0.5	8.3	0.6	1.2	7.0	32.2	1.2	11.5	2.2	13.5	5.7	17.4	7.2	20.5	75.1	1.5	0.6	9.5	3.8	1.7	0.3	1.1	1.1	6.0	1.1	5.5	1.0	2.8	2.1	19.8	3.1	5.9	1.8	17.9	2.4	1.2	7.3	69.6	1.0	1.1	14.7	3.2	0.5	0.2	3.5	2.2	0.3	51.6	12.8	3.0	0.0	0.0	0.0	0.7	0.4	1.8	0.0	2.5	16.1	22.7	0.0	0.0	2.4	0.5	0.0	2.9	0.6	1.9	0.2	0.0	2.2	0.4	0.0	11.7	0.0	1.1	0.0	3.7	34.2	3.8	3.8	1.6	0.0	0.3	0.0	0.0	1.8	0.0	0.2	0.2	0.0	0.2	1.1	0.0	0.1	31.4	0.0	0.8	0.0	0.0	0.0	0.0	0.0	5.6	3.4	0.0	0.6	3.2	0.1	0.0	0.0	12.1	1.6	1.4	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	1.6	0.0	0.4	0.0	3.0	0.0	0.2	0.0	0.7	0.0	0.0	0.0	1.8	0.7	0.9	0.6	1.2	1.5	0.6	1.1	1.1	2.1	0.5
S100P		ENSG00000163993	"S100 calcium binding protein P"	P25815	4	6693069-6697170	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 89.9;bone marrow: 42.8;stomach 1: 70.0;urinary bladder: 47.6"	"Cell line enhanced"	"Detected in some"		"BEWO: 37.2;Hep G2: 39.1;hTCEpi: 43.6;RT4: 80.0;SK-BR-3: 44.8"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 564.7"					"Group enriched"	"Detected in some"	41	"basophil: 47.8;eosinophil: 24.8;neutrophil: 89.9"	"Lineage enriched"	"Detected in many"	68	"granulocytes: 89.9"									HPA019502	Enhanced		Supported	"Nuclear bodies"		1200000	1200000	"Nuclear bodies"	"Nuclear bodies"	"HPA019502: AB_1856530"	"unprognostic (1.46e-1)"	"unprognostic (1.50e-1)"	"unprognostic (7.52e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.22e-1)"	"unprognostic (7.34e-2)"	"unprognostic (1.60e-3)"	"unprognostic (3.92e-2)"	"unprognostic (7.19e-2)"	"unprognostic (9.24e-2)"	"prognostic unfavourable (2.00e-4)"	"unprognostic (3.87e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.72e-1)"	"unprognostic (9.24e-2)"	"unprognostic (3.65e-1)"	"unprognostic (1.12e-2)"	0.1	0.0	0.0	1.1	0.0	42.8	0.0	0.0	0.0	0.3	5.2			0.1	0.0	0.0	23.3	0.3	1.0	0.0	0.0	0.0	0.0	1.9	2.4	0.0	0.0		0.0	0.0	0.0	0.0	16.4		4.8	5.4		1.1	0.0	0.0	3.9	0.5	0.1	0.0	4.4	70.0	0.0			0.0		2.5	47.6	5.1	0.0	0.0	89.9	1.3	0.0	0.0	0.4	5.0	3.2	0.0	0.0	0.0	0.0	37.2	0.0	0.0	0.0	0.0	0.1	0.7	0.0	1.8	0.0	6.2	0.0	0.0	0.0	2.4	0.0	0.1	3.6	39.1	0.0	2.3	0.1	0.0	43.6	0.0	0.0	0.0	0.1	0.0	0.0	7.1	0.0	4.5	0.0	5.7	0.0	0.0	0.0	0.0	80.0	0.0	0.0	7.3	44.8	0.0	1.2	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.1	0.0	47.8	1.3	24.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	89.9	0.0	0.1	0.0	0.0	0.4										
SBSPON	"C8orf84, RPESP"	ENSG00000164764	"Somatomedin B and thrombospondin type 1 domain containing"	Q8IVN8	8	73064540-73124088	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 66.7;urinary bladder: 47.9"	"Group enriched"	"Detected in some"	8	"BJ: 9.8;RPTEC TERT1: 17.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA029595	Approved		Approved	Vesicles	"Secreted to extracellular matrix"	19000	19000	Vesicles	Vesicles	"HPA029595: AB_10600763"	"prognostic favourable (7.18e-4)"	"unprognostic (5.08e-3)"	"unprognostic (3.24e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.78e-2)"	"unprognostic (8.65e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.46e-1)"	"unprognostic (9.54e-2)"	"unprognostic (1.06e-1)"	"prognostic unfavourable (8.82e-4)"	"unprognostic (6.14e-2)"	"unprognostic (3.54e-1)"	"unprognostic (2.12e-2)"	"unprognostic (6.25e-2)"	6.7	3.0	0.6	1.7	0.7	0.3	6.7	2.6	0.7	6.5	4.2	2.9	16.5	0.8	4.9	18.1	9.6	8.2	3.0	3.5	1.1	0.8	14.4	0.6	5.0	2.4	2.5	0.9	9.0	1.2	0.0	1.7	9.3	5.4	19.4	1.1	4.3	4.3	25.4	1.1	1.8	2.6	66.7	15.7	1.1	9.9	5.6	0.7	0.1	3.2	2.5	0.9	47.9	7.6	0.9	1.2	1.1	0.4	1.5	0.8	0.3	0.3	0.2	0.5	0.5	0.0	0.0	1.4	9.8	0.0	0.0	0.0	0.1	0.2	0.4	0.5	0.1	0.2	0.0	0.0	0.0	0.3	0.4	0.3	0.4	0.4	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.4	0.3	1.0	0.2	0.2	0.2	0.0	17.8	0.1	0.6	0.5	1.0	0.4	0.1	0.2	0.1	0.5	0.2	1.7	0.2	0.2	0.0	0.0	0.1	0.2	0.2	0.2	0.7	0.4	0.4	0.6	0.0	0.1	0.4	0.6	0.7	0.1	0.9	0.4	0.8	1.1	1.5	0.4	1.2	0.2	0.3	0.6	0.7	2.6	0.7	1.1	0.8	2.5	0.9	5.4	0.7
SFRP2	"FRP-2, SARP1, SDF-5"	ENSG00000145423	"Secreted frizzled related protein 2"	Q96HF1	4	153780592-153789120	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"urinary bladder: 102.5"	"Group enriched"	"Detected in some"	12	"AF22: 52.3;ASC diff: 19.9;HSkMC: 32.8;NTERA-2: 72.5"	"Cancer enhanced"	"Detected in all"		"pancreatic cancer: 370.9"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA002652			Approved	"Intermediate filaments"	"Secreted in other tissues"			"Intermediate filaments"	"Intermediate filaments"	"HPA002652: AB_2732394"	"unprognostic (2.63e-1)"	"unprognostic (2.47e-1)"	"unprognostic (7.21e-3)"	"unprognostic (1.80e-2)"	"unprognostic (2.73e-1)"	"unprognostic (8.80e-3)"	"unprognostic (5.71e-3)"	"unprognostic (2.62e-2)"	"unprognostic (2.79e-1)"	"unprognostic (7.47e-3)"	"unprognostic (1.44e-2)"	"unprognostic (5.29e-2)"	"prognostic unfavourable (8.56e-6)"	"unprognostic (9.29e-3)"	"unprognostic (4.72e-2)"	"unprognostic (1.05e-2)"	"prognostic unfavourable (4.39e-4)"	42.9	4.0	3.4	17.6	1.7	0.2	70.0	1.3	8.0	10.9	20.6	11.3	18.2	4.4	6.4	64.4	51.5	18.5	74.9	42.2	8.5	1.2	1.9	0.2	21.3	2.6	2.8	5.6	7.9	22.5	1.6	23.2	0.3	4.6	33.4	10.8	8.4	23.9	19.5	2.5	26.1	13.7	72.3	5.4	0.3	11.4	13.2	5.0	0.3	29.1	29.4	6.8	102.5	37.4	0.0	0.0	0.0	0.1	0.0	0.3	0.4	0.0	0.0	52.3	0.0	19.9	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	72.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.1	0.0	0.0	2.8	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	3.4	1.7	1.3	5.7	8.5	1.2	2.8	5.6	4.6	5.0
SHROOM1	"APXL2, KIAA1960"	ENSG00000164403	"Shroom family member 1"	Q2M3G4	5	132822141-132830898	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 42.7;urinary bladder: 37.8"	"Cell line enhanced"	"Detected in many"		"RT4: 19.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"classical monocyte: 3.7"	"Lineage enriched"	"Detected in single"	5	"monocytes: 3.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037690, HPA037691"	Uncertain		Approved	Vesicles				Vesicles	Vesicles	"HPA037690: AB_2675613, HPA037691: AB_2675614"	"unprognostic (2.50e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.52e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.45e-2)"	"unprognostic (3.47e-1)"	"unprognostic (9.26e-2)"	"unprognostic (1.33e-2)"	"unprognostic (3.74e-1)"	"unprognostic (3.24e-1)"	"unprognostic (2.46e-2)"	"unprognostic (1.01e-2)"	"prognostic unfavourable (5.72e-6)"	"unprognostic (8.22e-2)"	"unprognostic (2.91e-2)"	"unprognostic (2.88e-2)"	"unprognostic (2.26e-3)"	5.5	2.4	8.2	2.9	13.5	0.7	3.5	8.3	9.6	4.2	12.0	26.3	23.8	6.5	6.4	2.7	2.2	3.8	7.2	2.4	9.5	5.3	3.2	42.7	4.6	1.0	23.8	7.9	2.6	6.7	7.6	3.1	12.4	12.3	35.9	11.9	8.8	6.3	17.0	1.8	1.5	10.0	4.9	13.8	1.3	10.5	1.3	20.5	0.0	3.0	0.6	1.0	37.8	11.6	0.1	0.2	0.7	3.7	0.3	0.1	0.6	6.7	4.1	0.7	0.6	1.2	3.4	7.3	6.8	6.3	5.8	6.5	8.9	4.7	1.2	9.9	4.0	0.7	2.5	4.6	3.6	6.8	7.9	0.2	6.4	8.1	3.5	0.5	2.4	1.5	2.5	4.1	2.5	3.8	5.4	6.6	4.9	3.5	0.1	3.0	1.1	5.7	0.4	0.0	0.6	1.0	19.3	4.7	1.2	6.7	0.6	3.7	4.2	2.3	3.7	6.7	9.0	0.9	8.8	7.1	5.0	0.1	6.6	0.0	2.1	0.5	3.7	0.1	0.1	0.9	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.7	0.3	0.8	0.0	0.0	0.6	8.2	13.5	8.3	9.6	9.5	5.3	23.8	7.9	12.3	20.5
SLITRK6	FLJ22774	ENSG00000184564	"SLIT and NTRK like family member 6"	Q9H5Y7	13	85792787-85806683	"Disease related genes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"prostate: 24.2;salivary gland: 22.8;smooth muscle: 22.4;urinary bladder: 27.8"	"Cell line enhanced"	"Detected in some"		"hTCEpi: 13.3;RT4: 45.6;WM-115: 10.7"	"Cancer enhanced"	"Detected in many"		"breast cancer: 21.1"	"Group enriched"	"Detected in many"	4	"basal ganglia: 11.1;cerebellum: 4.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"thalamus: 24.7"	"Low region specificity"	"Detected in many"			"HPA014491, HPA014513"	Uncertain		Supported	"Plasma membrane"		9500	9500	"Plasma membrane"	"Plasma membrane"	"HPA014491: AB_10601603, HPA014513: AB_2669026"	"unprognostic (6.14e-2)"	"unprognostic (5.21e-3)"	"unprognostic (1.40e-1)"	"unprognostic (2.66e-2)"	"unprognostic (2.46e-2)"	"prognostic unfavourable (8.52e-4)"	"unprognostic (6.10e-2)"	"unprognostic (1.72e-2)"	"unprognostic (1.69e-1)"	"unprognostic (4.82e-2)"	"unprognostic (7.60e-2)"	"unprognostic (7.92e-2)"	"unprognostic (3.31e-5)"	"unprognostic (5.60e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.51e-2)"	0.4	0.3	0.3	2.7	11.1	0.0	2.9	4.9	0.3	1.0	4.5	0.0	0.2	2.8	0.7	3.4	3.6	0.3	1.1	1.9	0.3	1.3	0.3	1.1	3.1	0.0	0.6	0.0	0.3	0.4	0.0	0.4	4.1	0.8	24.2	5.8	1.7	22.8	1.8	0.3	4.5	7.2	22.4	0.4	0.2	1.2	0.5	1.8	0.0	0.6	3.4	0.7	27.8	5.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.2	0.0	0.0	0.0	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	2.2	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	13.3	0.0	1.5	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	45.6	0.4	0.5	0.2	0.0	0.0	0.2	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.4	0.0	10.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	11.1	4.9	0.3	0.3	1.3	0.6	0.0	0.8	1.8
SLMAP	"KIAA1601, SLAP"	ENSG00000163681	"Sarcolemma associated protein"	Q14BN4	3	57755450-57929168	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"smooth muscle: 133.6;urinary bladder: 114.2"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002357, HPA002358"	Enhanced		Approved	"Endoplasmic reticulum"		12000	12000	"Endoplasmic reticulum"	"Endoplasmic reticulum"	"HPA002357: AB_1080023, HPA002358: AB_1080021"	"unprognostic (3.70e-1)"	"unprognostic (2.87e-2)"	"unprognostic (1.82e-3)"	"unprognostic (3.43e-2)"	"unprognostic (3.34e-1)"	"unprognostic (6.18e-2)"	"unprognostic (1.47e-2)"	"prognostic unfavourable (7.98e-4)"	"unprognostic (1.23e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.59e-3)"	"unprognostic (1.06e-1)"	"prognostic favourable (1.58e-6)"	"unprognostic (8.18e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.92e-2)"	"unprognostic (6.08e-2)"	10.6	10.7	7.0	22.4	11.1	7.4	12.0	10.2	7.2	26.5	50.3	5.8	24.7	9.8	43.0	19.5	44.0	21.3	15.0	58.2	6.5	5.6	8.0	7.8	8.0	7.2	6.9	6.0	21.4	5.8	16.0	8.0	7.7	6.8	47.8	12.2	8.7	8.6	37.7	26.1	9.4	23.3	133.6	6.0	7.2	27.2	14.9	6.8	11.2	11.1	12.1	6.3	114.2	26.4	5.9	5.1	15.8	5.5	7.1	5.9	4.5	21.8	12.3	10.5	15.2	15.9	16.0	14.4	20.1	20.9	14.2	13.7	29.6	32.5	14.6	9.6	16.0	12.0	18.8	26.9	18.6	16.2	10.8	25.4	17.4	23.1	15.4	25.1	14.2	11.5	21.6	17.4	32.5	16.2	20.7	13.3	14.4	7.1	17.1	12.9	15.8	23.9	7.1	11.6	14.5	29.0	23.8	6.0	7.1	26.3	20.0	12.4	10.8	15.9	19.1	15.7	12.5	19.8	26.1	15.4	26.3	20.0	14.1	21.9	14.6	7.5	5.5	15.8	5.9	3.6	4.9	5.9	4.6	5.0	5.1	4.5	5.4	5.5	13.4	7.1	3.6	2.9	5.1	4.5	7.0	11.1	10.2	7.2	6.5	5.6	6.9	6.0	6.8	6.8
SNCG	"BCSG1, persyn, SR"	ENSG00000173267	"Synuclein gamma"	O76070	10	86958618-86963260	"Predicted intracellular proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 74.1;adrenal gland: 78.3;brain: 100.1;urinary bladder: 76.6"	"Group enriched"	"Detected in some"	4	"CAPAN-2: 93.7;RT4: 77.2"	"Group enriched"	"Detected in all"	8	"ovarian cancer: 84.1;urothelial cancer: 301.2"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 2.4;naive CD4 T-cell: 1.8"	"Low lineage specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"pons and medulla: 292.8"	"Low region specificity"	"Detected in many"			"CAB001452, HPA014404, CAB040581"	Enhanced	Supported	Supported	"Nuclear bodies,Centrosome"				Centrosome	Centrosome	"CAB001452: AB_564020, CAB040581: , HPA014404: AB_1857715"	"unprognostic (2.06e-1)"	"unprognostic (2.58e-1)"	"unprognostic (6.87e-3)"	"unprognostic (1.45e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.91e-1)"	"unprognostic (4.76e-3)"	"unprognostic (8.99e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.85e-3)"	"unprognostic (3.75e-1)"	"prognostic unfavourable (2.29e-8)"	"prognostic unfavourable (7.15e-4)"	"unprognostic (2.35e-1)"	"unprognostic (2.36e-2)"	"unprognostic (3.77e-3)"	74.1	78.3	82.3	5.3	20.8	1.0	28.9	12.3	44.5	9.5	5.8	4.6	6.4	4.8	6.1	12.0	11.0	26.5	6.2	9.0	40.0	92.9	4.1	1.9	4.6	4.9	72.9	35.1	15.0	3.5	1.6	1.7	4.9	100.1	11.9	2.7	10.8	10.9	44.4	6.6	8.5	5.4	5.8	35.2	20.2	2.6	2.9	5.3	0.2	3.4	3.3	9.6	76.6	18.3	0.0	0.7	0.0	2.4	0.0	1.8	0.6	0.2	1.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.1	93.7	0.0	1.9	0.1	7.8	0.0	0.3	0.0	0.0	0.0	0.5	18.2	0.3	0.1	0.0	0.1	0.4	7.3	0.0	0.0	6.6	0.6	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	77.2	0.0	0.0	0.6	1.0	0.1	20.3	0.0	17.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.1	0.0	2.4	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.7	0.0	1.8	0.0	0.0	0.0	0.9	0.0	0.0	0.6	82.3	20.8	12.3	44.5	40.0	92.9	72.9	35.1	100.1	5.3
SNX31	MGC39715	ENSG00000174226	"Sorting nexin 31"	Q8N9S9	8	100572882-100663415	"Predicted intracellular proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 21.4;prostate: 13.8;urinary bladder: 25.4;vagina: 16.0"	"Cell line enriched"	"Detected in single"	50	"RT4: 41.9"	"Cancer enriched"	"Detected in many"	22	"urothelial cancer: 24.2"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"neutrophil: 3.0"	"Low lineage specificity"	"Detected in many"			"Region enriched"	"Detected in single"	5	"thalamus: 2.9"	"Group enriched"	"Detected in some"	4	"basal ganglia: 0.8;olfactory region: 3.1"	"HPA024284, HPA053466"	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"				"Nucleoplasm, Golgi apparatus"	"Nucleoplasm, Golgi apparatus"	"HPA024284: AB_1853894, HPA053466: AB_2682161"	"unprognostic (1.39e-1)"	"unprognostic (3.83e-2)"	"unprognostic (7.99e-2)"	"unprognostic (1.52e-1)"	"unprognostic (7.20e-5)"	"unprognostic (1.04e-1)"	"unprognostic (1.01e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.21e-1)"	"unprognostic (2.09e-2)"	"unprognostic (1.69e-1)"	"unprognostic (7.79e-3)"	"unprognostic (1.66e-1)"	"prognostic favourable (1.47e-4)"	"unprognostic (2.54e-1)"	"unprognostic (4.05e-2)"	0.5	0.0	0.6	0.1	0.7	0.1	0.4	0.6	2.3	1.7	0.3	0.3	0.1	0.2	0.3	0.2	6.2	0.3	0.9	1.8	0.8	0.7	0.3	0.4	0.3	0.3	0.9	0.3	0.3	0.2	0.1	0.2	0.1	0.6	13.8	0.1	0.4	1.4	0.1	1.0	0.5	0.1	7.4	0.8	0.1	0.6	3.3	0.5	0.1	0.4	2.6	21.4	25.4	16.0	1.1	0.3	3.0	0.5	1.6	0.3	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	41.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.8	0.1	2.5	0.5	0.2	0.3	0.2	0.1	1.1	0.1	0.2	0.2	0.5	0.1	0.3	3.0	1.6	0.0	0.3	0.0	0.0	0.6	0.7	0.6	0.3	0.8	0.7	0.9	0.3	0.6	0.5
SORBS2	"ARGBP2, KIAA0777"	ENSG00000154556	"Sorbin and SH3 domain containing 2"	O94875	4	185585444-185956652	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 141.4;urinary bladder: 126.4"	"Cell line enhanced"	"Detected in many"		"AF22: 66.7;TIME: 35.9;WM-115: 19.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"memory B-cell: 1.3"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"unprognostic (3.30e-2)"	"unprognostic (5.09e-2)"	"unprognostic (1.20e-1)"	"prognostic favourable (6.07e-5)"	"unprognostic (1.61e-2)"	"unprognostic (1.09e-1)"	"prognostic favourable (1.47e-5)"	"unprognostic (1.28e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.20e-1)"	"unprognostic (8.30e-2)"	"unprognostic (1.72e-1)"	"prognostic favourable (3.10e-6)"	"unprognostic (1.26e-1)"	"unprognostic (2.42e-1)"	"unprognostic (2.79e-3)"	"unprognostic (2.51e-2)"	10.3	45.6	6.3	13.7	11.3	0.4	10.0	4.3	9.9	16.5	27.4	2.7	16.7	2.9	11.1	13.7	44.5	9.9	26.6	141.4	5.6	4.7	8.7	31.8	5.1	1.5	4.4	5.4	8.2	28.9	46.9	12.8	17.0	7.9	52.7	6.9	43.3	17.9	21.9	6.5	3.1	6.1	111.0	3.6	6.5	15.3	4.4	2.8	2.4	71.2	9.0	4.5	126.4	29.0	1.3	0.0	0.5	0.0	0.0	0.2	1.3	0.1	0.1	66.7	0.0	9.5	16.7	3.3	0.1	0.0	0.0	0.1	1.7	5.2	0.0	7.2	0.6	0.0	0.0	2.4	0.0	0.0	1.0	0.9	5.2	4.2	0.0	0.0	0.0	6.2	0.7	10.0	0.7	12.3	0.0	0.0	0.7	0.0	0.0	0.1	6.3	0.0	6.1	0.0	0.0	9.1	1.6	8.3	2.5	0.0	0.0	3.7	2.0	0.0	35.9	5.0	0.6	0.0	2.4	0.0	0.0	0.0	11.1	0.0	19.9	0.0	0.0	0.0	0.2	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	1.3	6.3	11.3	4.3	9.9	5.6	4.7	4.4	5.4	7.9	2.8
SPOCD1	"FLJ25348, PPP1R146"	ENSG00000134668	"SPOC domain containing 1"	Q6ZMY3	1	31790422-31816051	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 28.9;urinary bladder: 13.7"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 18.6;hTEC/SVTERT24-B: 19.3;RT4: 32.6;TIME: 16.9;U-87 MG: 32.1"	"Group enriched"	"Detected in many"	7	"glioma: 13.9;urothelial cancer: 5.6"	"Region enhanced"	"Detected in many"		"pons and medulla: 8.2"	"Cell type enriched"	"Detected in single"	15	"neutrophil: 1.9"	"Lineage enriched"	"Detected in single"	15	"granulocytes: 1.9"					"Low region specificity"	"Detected in some"			"HPA031713, HPA031714, HPA031715"	Enhanced		Approved	Nucleoplasm,Nucleoli,Cytosol				Cytosol	Cytosol	"HPA031713: AB_10604099, HPA031714: AB_2674007, HPA031715: "	"unprognostic (7.78e-2)"	"unprognostic (2.58e-2)"	"unprognostic (1.85e-3)"	"unprognostic (2.70e-3)"	"unprognostic (1.29e-2)"	"unprognostic (1.56e-2)"	"unprognostic (2.15e-3)"	"unprognostic (2.60e-2)"	"unprognostic (3.51e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.01e-2)"	"unprognostic (3.00e-1)"	"unprognostic (0.00e+0)"	"unprognostic (1.97e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.54e-2)"	"prognostic favourable (4.05e-5)"	28.9	0.5	1.8	5.1	1.6	0.3	1.6	0.4	3.9	2.0	0.7	1.5	0.1	1.6	2.4	2.8	0.3	2.1	1.6	0.4	1.2	1.6	0.5	0.2	12.9	0.9	2.6	0.3	1.8	0.1	0.1	1.6	3.5	8.2	1.8	0.9	1.8	0.1	0.3	0.4	0.1	0.9	2.4	3.1	1.9	1.1	11.9	0.6	0.1	0.4	0.8	0.2	13.7	2.1	0.0	0.0	1.9	0.1	0.0	0.0	7.3	10.6	0.3	0.0	0.0	0.2	1.5	0.5	13.9	18.6	13.5	9.0	0.2	0.6	0.1	1.9	15.6	1.4	0.0	0.2	4.3	0.0	0.0	0.0	1.9	0.0	0.6	0.0	0.2	6.8	0.2	19.3	0.6	9.1	0.2	0.2	7.9	0.0	0.1	0.0	0.2	0.3	0.0	1.4	0.0	0.0	32.6	0.0	0.0	0.3	0.0	0.9	8.0	0.0	16.9	14.2	1.4	9.2	5.2	0.0	0.1	0.0	32.1	0.0	2.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	7.3	1.8	1.6	0.4	0.6	1.2	1.6	2.6	0.3	8.2	0.6
STON1-GTF2A1L	SALF	ENSG00000068781	"STON1-GTF2A1L readthrough"		2	48529925-48776517	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in many"		"urinary bladder: 31.6"	"Cell line enhanced"	"Detected in some"		"AF22: 2.0;ASC diff: 5.5;ASC TERT1: 5.2;HSkMC: 3.7"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"cerebellum: 6.3;midbrain: 3.2;pons and medulla: 12.0"	"Cell type enhanced"	"Detected in single"		"MAIT T-cell: 1.0"	"Low lineage specificity"	"Detected in single"											HPA005715	Uncertain									"HPA005715: AB_1080113"	"unprognostic (5.66e-3)"	"unprognostic (8.85e-2)"	"unprognostic (1.18e-3)"		"unprognostic (8.26e-2)"	"unprognostic (5.08e-2)"		"unprognostic (3.53e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.15e-1)"	"unprognostic (7.59e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.46e-2)"	9.4	1.8	1.5	5.7	1.5	0.7	7.3	6.3	1.4	15.1	12.7	2.2	4.4	1.4	20.5	4.6	13.2	5.0	7.9	2.4	1.5	1.5	3.9	1.5	4.7	1.7	3.2	0.0	13.2	1.5	0.8	1.8	7.5	12.0	14.1	3.7	5.5	1.5	5.6	1.6	1.6	3.0	30.3	22.2	7.8	5.3	2.9	0.7	0.8	3.5	0.6	0.8	31.6	15.1	0.0	0.0	0.7	0.0	0.6	1.0	0.0	0.0	0.2	2.0	0.0	5.5	5.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.3	1.5	0.0	0.0	0.0	0.5	0.1	0.0	0.0	1.7	0.0	0.3	3.7	0.3	0.0	0.1	1.0	0.1	0.0	0.3	0.0	0.0	0.0	1.5	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.5	1.5	6.3	1.4	1.5	1.5	3.2	0.0	12.0	0.7
SYNM	"DMN, KIAA0353, SYN"	ENSG00000182253	Synemin	O15061	15	99098217-99135593	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 111.2;smooth muscle: 147.5;urinary bladder: 85.2"	"Cell line enhanced"	"Detected in many"		"A549: 14.6;HeLa: 21.9;WM-115: 49.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Lineage enriched"	"Detected in single"	8	"T-cells: 1.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017192, HPA040066, HPA044200, HPA077856"	Enhanced		Supported	"Intermediate filaments"				"Intermediate filaments"	"Intermediate filaments"	"CAB017192: , HPA040066: AB_2676830, HPA044200: AB_2678854, HPA077856: "	"unprognostic (1.04e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.00e-2)"	"unprognostic (6.10e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.52e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.34e-2)"	"unprognostic (6.75e-2)"	"unprognostic (3.54e-3)"	"unprognostic (2.80e-2)"	"unprognostic (7.27e-2)"	"unprognostic (5.92e-3)"	"unprognostic (3.26e-3)"	6.9	4.2	4.5	5.0	5.4	0.0	11.9	2.5	5.5	2.9	38.4	9.0	27.6	5.4	4.9	7.2	42.1	3.1	9.6	24.8	6.0	5.7	0.8	0.8	2.0	0.7	11.8	4.2	2.9	0.9	1.8	2.0	2.7	8.5	30.1	11.1	10.9	3.2	62.6	111.2	1.5	11.9	147.5	18.2	0.6	16.7	1.5	3.7	0.0	1.4	14.5	1.7	85.2	21.6	0.2	0.1	0.1	0.0	0.2	1.8	0.4	2.5	14.6	3.2	8.7	6.6	0.3	0.2	1.4	2.1	0.8	0.5	2.1	1.9	0.0	2.1	2.1	1.6	2.2	0.0	0.6	0.2	3.6	0.0	21.9	2.1	3.7	0.0	0.4	0.4	0.1	1.4	0.3	1.7	0.0	2.9	2.2	1.4	0.2	0.3	2.9	4.6	0.0	3.0	2.1	0.8	1.4	1.4	1.7	8.6	1.3	5.2	0.0	1.4	1.9	1.6	0.2	1.1	3.4	0.0	0.4	0.0	0.1	0.0	49.6	0.1	0.0	0.0	1.7	0.0	1.4	0.2	1.8	1.1	0.1	0.0	1.6	0.6	0.0	0.2	0.0	0.0	0.0	0.4	4.5	5.4	2.5	4.4	6.0	5.7	11.8	4.2	8.5	3.7
SYT8	DKFZp434K0322	ENSG00000149043	"Synaptotagmin 8"	Q8NBV8	11	1828307-1837521	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 61.8;skin 1: 41.6;urinary bladder: 31.4"	"Group enriched"	"Detected in some"	5	"CAPAN-2: 27.1;hTCEpi: 43.2;T-47d: 11.6"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 33.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA052700	Uncertain									"HPA052700: AB_2681920"	"unprognostic (1.66e-3)"	"unprognostic (2.42e-1)"	"unprognostic (1.12e-2)"	"unprognostic (2.14e-1)"	"unprognostic (6.31e-2)"	"unprognostic (2.06e-1)"	"unprognostic (3.10e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.02e-1)"	"unprognostic (8.25e-2)"	"unprognostic (7.09e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.33e-6)"	"unprognostic (2.87e-2)"	"unprognostic (1.75e-1)"	"unprognostic (5.52e-2)"	"unprognostic (2.77e-2)"	0.1	0.1	0.0	0.1	0.0	0.0	3.5	0.0	0.0	0.7	0.9	0.0	6.8	0.7	0.1	7.3	19.9	0.6	61.8	0.1	0.1	0.0	0.5	0.3	2.3	0.0	0.0	0.0	0.1	7.8	0.0	0.1	5.7	0.0	5.6	0.1	0.3	11.8	4.2	0.1	41.6	3.6	6.3	0.1	0.1	3.1	0.1	0.0	0.0	0.1	19.4	13.3	31.4	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	27.1	0.0	0.0	0.0	0.5	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	43.2	0.0	5.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.8	0.0	0.2	0.0	2.3	0.0	11.6	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0
TACR3	NK3R	ENSG00000169836	"Tachykinin receptor 3"	P29371	4	103586031-103719816	"Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 14.4;urinary bladder: 5.5"	"Cell line enriched"	"Detected in single"	13	"BEWO: 12.6"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"amygdala: 14.4;hypothalamus: 4.1;pons and medulla: 6.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA009418	Uncertain									"HPA009418: AB_1857727"	"unprognostic (3.81e-2)"				"unprognostic (2.92e-1)"	"unprognostic (2.29e-1)"		"unprognostic (3.50e-1)"		"unprognostic (3.21e-1)"				"unprognostic (5.52e-1)"	"unprognostic (3.80e-1)"	"unprognostic (3.42e-2)"	"unprognostic (1.72e-2)"	0.1	0.1	14.4	0.1	1.4	0.1	0.4	0.0	2.6	0.1	0.4	0.0	0.0	0.1	0.2	0.4	0.2	0.3	0.3	0.1	1.1	4.1	2.0	0.1	0.9	0.1	1.4	1.0	0.1	0.1	0.1	0.1	0.6	6.3	0.2	0.5	3.2	0.1	0.1	0.7	0.3	0.1	0.1	2.5	0.1	0.5	0.6	0.0	0.0	0.5	0.9	0.1	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	12.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.4	1.4	0.0	1.5	1.1	4.1	1.4	1.0	6.3	0.0
TBX20		ENSG00000164532	"T-box 20"	Q9UMR3	7	35202430-35254147	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"gallbladder: 26.5;heart muscle: 46.4;prostate: 24.2;smooth muscle: 47.0;urinary bladder: 32.3"	"Cell line enhanced"	"Detected in some"		"HHSteC: 4.7;HMC-1: 5.3;RH-30: 5.2;SH-SY5Y: 9.9;WM-115: 5.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"														"unprognostic (2.20e-1)"		"unprognostic (1.25e-2)"	"unprognostic (1.87e-2)"				"unprognostic (8.47e-2)"		"unprognostic (3.95e-2)"				"unprognostic (2.75e-1)"	"unprognostic (1.74e-1)"		"unprognostic (9.75e-2)"	0.2	4.3	0.2	0.1	0.2	0.1	0.2	0.2	0.2	0.2	0.2	0.0	0.0	0.1	0.2	0.1	0.2	0.2	26.5	46.4	0.2	0.2	0.2	0.6	0.2	0.1	0.2	0.0	0.2	0.2	0.1	1.8	15.1	0.0	24.2	0.1	2.7	0.2	0.1	0.2	0.2	0.2	47.0	0.2	0.2	0.2	0.4	0.0	0.0	0.2	0.0	0.1	32.3	14.4	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	3.3	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	2.2	3.1	0.0	0.6	0.0	0.3	4.2	0.0	0.1	2.2	3.4	4.2	1.4	0.0	4.7	0.0	5.3	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.6	0.0	5.2	0.0	0.1	0.0	0.2	9.9	0.5	0.0	0.0	0.0	3.7	0.0	0.0	0.2	3.6	0.0	0.4	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.0	0.0
THBS2	TSP2	ENSG00000186340	"Thrombospondin 2"	P35442	6	169215780-169254044	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 84.6;urinary bladder: 67.4"	"Cell line enhanced"	"Detected in some"		"ASC diff: 81.9;ASC TERT1: 56.2;BJ hTERT+ SV40 Large T+ RasG12V: 27.2;HSkMC: 30.3;hTEC/SVTERT24-B: 29.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB017716, HPA044304"	Approved		Approved	"Nuclear speckles,Plasma membrane,Cytosol"	"Secreted to extracellular matrix"	22000000	22000000	"Plasma membrane"	"Plasma membrane"	"CAB017716: , HPA044304: AB_2678891"	"unprognostic (2.85e-2)"	"unprognostic (1.41e-1)"	"unprognostic (5.87e-2)"	"unprognostic (8.90e-2)"	"unprognostic (3.64e-2)"	"unprognostic (8.73e-2)"	"unprognostic (2.93e-1)"	"unprognostic (5.10e-3)"	"unprognostic (1.39e-1)"	"unprognostic (4.71e-2)"	"unprognostic (4.00e-2)"	"unprognostic (2.56e-1)"	"prognostic unfavourable (3.77e-6)"	"unprognostic (2.19e-3)"	"unprognostic (4.38e-2)"	"unprognostic (4.16e-2)"	"unprognostic (2.48e-3)"	43.5	4.0	4.3	10.1	7.8	0.4	84.6	1.1	9.0	24.3	17.0	6.3	3.3	1.9	26.1	16.1	9.8	14.8	43.0	21.9	5.5	3.6	4.6	5.9	8.4	3.8	8.1	1.4	26.2	5.9	1.5	4.4	2.0	14.8	10.5	3.4	0.7	3.9	2.8	14.6	22.7	3.8	22.0	16.0	2.8	2.6	12.5	5.2	0.0	13.2	10.6	4.8	67.4	29.4	0.4	0.7	0.2	0.8	0.1	0.3	0.0	0.0	0.0	0.5	0.3	81.9	56.2	0.0	15.6	21.4	21.6	27.2	0.1	0.0	0.0	0.0	18.6	0.0	0.6	0.8	12.4	0.0	0.0	0.0	0.0	0.0	22.9	0.0	0.0	30.3	0.0	29.2	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.8	3.3	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	9.9	0.1	22.0	1.8	0.0	0.3	0.0	6.1	0.1	0.5	0.0	0.8	0.2	0.2	0.5	0.0	0.4	0.1	0.0	0.2	0.3	0.1	0.3	0.0	0.1	0.5	0.7	0.2	0.0	4.3	7.8	1.1	3.1	5.5	3.6	8.1	1.4	14.8	5.2
TMPRSS4	"MT-SP2, TMPRSS3"	ENSG00000137648	"Transmembrane serine protease 4"	Q9NRS4	11	118077012-118121890	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 60.9;gallbladder: 45.4;lymphoid tissue: 41.0;urinary bladder: 43.9"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 44.9;HaCaT: 19.2;RPTEC TERT1: 31.5;RT4: 39.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	5	"basophil: 4.5"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 4.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA006238	Uncertain		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Nucleoplasm	"HPA006238: AB_1080316"	"unprognostic (1.48e-1)"	"unprognostic (3.27e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.23e-1)"	"unprognostic (5.23e-2)"	"unprognostic (5.50e-2)"	"unprognostic (8.17e-3)"	"unprognostic (1.95e-2)"	"unprognostic (2.41e-1)"	"unprognostic (9.62e-2)"	"prognostic unfavourable (3.14e-4)"	"unprognostic (2.87e-3)"	"unprognostic (2.80e-1)"	"unprognostic (4.58e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.10e-2)"	"unprognostic (9.96e-3)"	0.3	0.3	0.2	14.2	0.3	0.0	0.3	0.3	0.2	11.4	23.5	0.1	0.0	16.1	3.1	2.8	60.9	0.6	45.4	0.3	0.3	0.3	17.7	0.3	3.2	0.0	0.2	0.0	0.3	0.4	0.0	0.3	0.8	0.1	9.9	26.2	0.2	4.0	0.0	0.3	2.4	27.4	4.2	0.2	0.3	13.7	0.7	0.0	0.6	0.3	13.7	41.0	43.9	22.3	0.5	0.1	4.5	0.7	0.2	0.1	0.0	8.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.0	44.9	0.0	1.7	0.0	19.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.2	0.1	0.0	0.4	0.1	1.3	0.0	0.0	0.0	0.0	0.0	31.5	39.3	0.0	0.0	0.0	3.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	4.5	0.1	0.3	0.1	0.1	0.1	0.2	0.1	0.1	0.0	0.5	0.1	0.1	0.9	0.2	0.7	0.1	0.1	0.0	0.2	0.3	0.3	0.2	0.3	0.3	0.2	0.0	0.1	0.0
TRIM31	"C6orf13, HCG1, HCGI, RNF"	ENSG00000204616	"Tripartite motif containing 31"	Q9BZY9	6	30102897-30113106	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 16.3;lymphoid tissue: 7.4;urinary bladder: 12.2"	"Cell line enriched"	"Detected in single"	490	"RT4: 79.5"	"Group enriched"	"Detected in many"	5	"cervical cancer: 6.7;colorectal cancer: 25.8;pancreatic cancer: 11.4;stomach cancer: 19.8;urothelial cancer: 12.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA046400	Uncertain									"HPA046400: AB_2679652"	"unprognostic (1.37e-1)"	"unprognostic (7.78e-3)"	"unprognostic (1.83e-1)"	"unprognostic (7.05e-3)"	"unprognostic (1.75e-1)"	"unprognostic (9.37e-2)"	"unprognostic (6.13e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.97e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.43e-3)"	"unprognostic (5.84e-3)"	"unprognostic (6.20e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.50e-3)"	0.1	0.0	0.1	7.4	0.1	0.0	0.1	0.1	0.1	0.2	16.3	0.1	0.1	1.2	0.1	0.1	0.1	0.1	3.3	0.1	0.1	0.0	0.1	1.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	2.1	0.4	0.1	0.1	0.1	0.1	0.1	13.7	0.7	0.1	0.1	4.8	2.0	0.1	0.1	0.1	0.1	0.1	12.2	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	79.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
TRPA1	ANKTM1	ENSG00000104321	"Transient receptor potential cation channel subfamily A member 1"	O75762	8	72019917-72075617	"Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 20.8;urinary bladder: 20.1;vagina: 12.1"	"Cell line enriched"	"Detected in some"	6	"HHSteC: 24.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"memory CD8 T-cell: 2.6"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"														"unprognostic (2.14e-2)"	"unprognostic (2.50e-2)"	"prognostic favourable (6.57e-4)"	"unprognostic (1.28e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.37e-2)"	"unprognostic (8.11e-3)"	"unprognostic (4.22e-2)"	"unprognostic (2.47e-1)"	"unprognostic (2.78e-3)"	"unprognostic (1.49e-1)"	"unprognostic (2.16e-4)"	"unprognostic (2.37e-1)"	"unprognostic (9.67e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.90e-1)"	0.3	0.2	0.2	9.1	0.2	0.0	0.2	0.2	0.4	0.4	16.8	0.3	0.0	4.8	0.2	0.3	2.2	0.2	5.7	0.3	0.2	0.2	0.2	0.2	0.3	0.8	0.3	0.0	0.4	0.2	0.0	0.2	0.3	0.1	4.7	7.5	0.0	0.2	0.0	0.2	0.2	20.8	3.8	0.2	0.4	7.9	0.4	0.0	0.6	0.2	0.3	1.4	20.1	12.1	0.5	0.6	0.1	1.1	0.3	2.6	0.2	0.0	2.4	0.7	0.0	0.0	0.1	0.0	0.3	2.2	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.4	1.3	0.1	0.0	0.5	0.0	24.1	0.0	0.2	1.6	0.0	1.1	0.2	0.0	0.0	0.0	2.9	0.0	0.0	0.1	0.5	0.0	0.0	1.2	0.0	0.0	0.0	0.1	0.1	0.4	0.0	2.3	0.0	0.3	0.0	0.1	3.8	1.1	0.0	0.3	0.2	0.0	1.8	0.0	1.7	0.0	0.0	0.0	0.3	0.0	1.1	0.5	0.5	2.6	0.0	0.5	0.0	0.4	0.1	0.3	1.1	0.6	1.0	0.2	0.2	0.2	0.2	0.4	0.2	0.2	0.3	0.0	0.1	0.0
UGT1A8	UGT1H	ENSG00000242366	"UDP glucuronosyltransferase family 1 member A8"	Q9HAW9	2	233617645-233773310	"Enzymes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 13.0;urinary bladder: 15.7"	"Cell line enriched"	"Detected in single"	58	"RT4: 51.2"	"Cancer enhanced"	"Detected in some"		"urothelial cancer: 2.4"					"Not detected"	"Not detected"			"Not detected"	"Not detected"																								"unprognostic (1.27e-2)"			"unprognostic (1.35e-1)"	"unprognostic (1.42e-3)"				"unprognostic (1.23e-1)"	"unprognostic (4.78e-1)"	"unprognostic (9.71e-12)"	"unprognostic (9.26e-2)"			"unprognostic (1.96e-1)"	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	13.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0		4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	7.3	0.0	0.0	0.0	0.0	0.0	3.3	5.5	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	3.0	15.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	51.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
UPK1A	TSPAN21	ENSG00000105668	"Uroplakin 1A"	O00322	19	35666516-35678483	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"prostate: 20.3;urinary bladder: 80.6"	"Cell line enriched"	"Detected in some"	11	"RT4: 29.2"	"Cancer enriched"	"Detected in many"	41	"urothelial cancer: 148.1"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA049879	Enhanced									"HPA049879: AB_2680929"	"unprognostic (3.29e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.19e-3)"	"unprognostic (3.40e-4)"	"unprognostic (4.05e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.74e-2)"	"unprognostic (3.11e-3)"	"unprognostic (2.30e-1)"	"unprognostic (1.78e-1)"	"unprognostic (4.62e-2)"	"unprognostic (2.34e-1)"	"unprognostic (2.48e-9)"	"unprognostic (1.48e-1)"	"unprognostic (4.14e-2)"	"unprognostic (2.45e-2)"	"unprognostic (1.72e-1)"	0.3	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	6.0	0.1	0.1	0.1	0.0	0.4	0.1	12.8	0.2	0.1	0.1	0.1	0.0	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	20.3	0.0	0.1	0.9	0.1	0.1	6.7	0.1	4.5	0.1	0.1	0.0	0.2	0.1	0.1	0.1	1.1	1.0	80.6	8.6	1.7	0.5	1.8	0.5	1.6	2.0	0.8	0.1	0.9	0.1	0.2	0.3	0.1	0.3	0.2	0.0	0.1	0.4	1.0	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	2.7	0.7	0.0	0.3	0.2	0.1	0.1	0.4	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.4	0.2	0.0	0.1	0.0	0.0	29.2	0.1	0.3	0.4	0.3	0.5	0.2	0.3	0.9	0.0	1.2	0.1	0.2	0.1	0.4	0.0	0.1	0.1	0.2	1.1	0.5	0.2	0.3	0.4	0.5	0.6	2.0	0.6	0.2	1.7	0.1	0.6	1.8	1.6	0.1	0.5	0.0	0.8	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
UPK1B	"TSPAN20, UPK1"	ENSG00000114638	"Uroplakin 1B"	O75841	3	119173517-119205153	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 56.4;urinary bladder: 41.9"	"Group enriched"	"Detected in some"	4	"CACO-2: 15.0;RPTEC TERT1: 14.0;RT4: 54.2"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 147.3"	"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"HPA031799, HPA031800"	Enhanced									"HPA031799: AB_10671579, HPA031800: AB_10671580"	"unprognostic (1.20e-2)"	"unprognostic (7.18e-2)"		"prognostic favourable (3.87e-5)"	"unprognostic (2.22e-1)"	"unprognostic (1.39e-1)"		"unprognostic (8.77e-3)"	"unprognostic (3.67e-1)"	"unprognostic (2.71e-1)"	"unprognostic (3.26e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.92e-2)"	"prognostic unfavourable (7.76e-4)"	"unprognostic (1.68e-1)"	"unprognostic (6.76e-2)"	"unprognostic (2.95e-2)"	6.1	0.2	0.2	0.2	1.2	0.0	0.2	0.2	0.3	3.6	0.7	0.0	0.0	0.0	1.5	0.3	2.4	5.1	12.9	1.8	0.2	0.2	6.6	0.6	1.4	0.0	0.2	0.1	0.8	11.6	0.0	0.4	56.4	1.1	15.4	0.0	0.0	0.4	0.0	0.2	0.6	0.2	4.3	1.8	0.2	22.9	0.7	0.0	1.4	0.2	1.4	12.9	41.9	1.1	0.7	1.1	2.5	0.5	0.6	1.9	0.5	0.0	6.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	15.0	0.0	0.0	2.0	0.0	0.4	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	14.0	54.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.5	0.5	0.3	0.3	0.2	0.4	0.2	0.3	0.5	0.7	1.9	0.3	1.8	0.6	0.4	1.1	0.2	0.5	0.2	1.2	0.2	0.3	0.2	0.2	0.2	0.1	1.1	0.0
UPK3A	UPK3	ENSG00000100373	"Uroplakin 3A"	O75631	22	45284982-45295874	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 33.7;skeletal muscle: 24.5;urinary bladder: 45.5"	"Group enriched"	"Detected in some"	5	"Hep G2: 18.3;RT4: 30.6"	"Group enriched"	"Detected in many"	6	"prostate cancer: 35.3;urothelial cancer: 78.0"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	11	"classical monocyte: 8.5;intermediate monocyte: 9.6;myeloid DC: 33.7;non-classical monocyte: 11.3;plasmacytoid DC: 13.0"	"Group enriched"	"Detected in many"	16	"dendritic cells: 33.7;monocytes: 11.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA018407, HPA018415"	Enhanced		Uncertain	"Nuclear membrane,Nuclear bodies"				"Nuclear membrane"	"Nuclear membrane"	"HPA018407: AB_1858641, HPA018415: AB_1858640"	"unprognostic (1.27e-2)"	"unprognostic (3.20e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.21e-1)"	"unprognostic (9.42e-2)"	"unprognostic (3.98e-5)"	"unprognostic (1.69e-2)"	"unprognostic (4.82e-4)"	"unprognostic (1.50e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.18e-1)"	"unprognostic (6.49e-5)"	"unprognostic (2.01e-2)"	"unprognostic (5.45e-2)"	"unprognostic (1.83e-1)"	"unprognostic (6.05e-3)"	0.2	0.1	0.3	1.6	0.4	0.9	0.3	0.2	0.5	0.4	0.7	0.0	0.0	0.0	0.2	2.3	0.2	0.2	0.6	0.2	0.3	0.3	0.2	0.2	0.2	1.0	0.4	0.1	0.2	0.2	6.4	0.5	0.0	0.7	17.9	0.5	0.6	12.9	1.8	24.5	0.2	1.8	13.0	0.3	0.7	0.2	0.2	0.0	1.3	4.6	1.7	0.6	45.5	2.7	0.3	33.7	1.4	11.3	0.1	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.3	0.0	2.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	5.1	0.0	0.0	0.0	0.0	0.1	0.0	30.6	0.1	0.0	0.1	0.5	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	8.5	0.0	0.0	9.6	0.0	0.3	0.0	0.0	33.7	0.2	0.0	0.0	1.4	0.1	11.3	13.0	0.0	2.8	0.3	0.4	0.2	0.5	0.3	0.3	0.4	0.1	0.7	0.0
WFDC10B	WAP12	ENSG00000182931	"WAP four-disulfide core domain 10B"	Q8IUB3	20	45684653-45705019	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"epididymis: 27.3;testis: 5.9;urinary bladder: 8.0"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 2.0;Daudi: 2.7;HHSteC: 2.2;hTEC/SVTERT24-B: 1.8;PC-3: 5.6;U-87 MG: 2.6"	"Cancer enhanced"	"Detected in some"		"lung cancer: 1.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																"Secreted in male reproductive system"						"unprognostic (1.14e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.37e-4)"	"unprognostic (1.60e-1)"	"unprognostic (2.69e-1)"	"unprognostic (4.81e-2)"		"unprognostic (4.30e-3)"		"unprognostic (5.64e-2)"	"unprognostic (1.14e-2)"	"unprognostic (3.36e-1)"	"unprognostic (0.00e+0)"	"unprognostic (1.39e-1)"	"unprognostic (3.15e-2)"	"unprognostic (2.21e-2)"	"unprognostic (3.17e-1)"	0.2	0.0	0.2	0.2	0.2	0.0	0.3	0.2	0.2	0.2	0.6	0.2	0.2	0.0	0.3	27.3	0.2	0.3	0.2	0.2	0.2	0.1	0.2	0.2	0.9	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.3	0.2	1.0	0.5	0.2	0.2	0.2	0.2	1.5	0.2	0.3	0.2	0.2	0.4	5.9	0.2	0.2	0.2	0.2	0.2	8.0	0.2	0.0	0.0	0.0	0.1	0.0	0.1	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.3	0.0	0.0	0.0	2.0	2.7	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.5	0.0	1.8	0.0	0.0	0.0	0.0	0.6	0.7	0.0	0.0	0.8	5.6	0.0	0.3	0.0	0.6	0.0	1.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.3	0.0	0.2	0.0	0.0	2.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.2	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.2
